| Article | Date | Source |
|---|
| Hearing in Abbott homicide case continued | -- | Pharmaceutical - Moreover |
| Kerala drug authorities register case against Geltec & Abbott for selling vitamin products without licence | -- | Pharmaceutical - Moreover |
| Abbott receives FDA approval for Lupron Depot | -- | Pharmaceutical - Moreover |
| Depakote Birth Injury Resources Evaluating Abbott Laboratories for... | -- | PRWeb - Pharmaceuticals |
| Abbott outbids Biogen for Facet's multiple sclerosis antibody | -- | Nature Biotechnology |
| Pfizer, Novartis, Eli Lilly, Myriad Pharmaceuticals, Abbott Laboratories, Purdue Pharmaceutical Discuss Legislative Changes & Supply Chain Strategy | -- | PRWeb - Pharmaceuticals |
| Abbott hit with record fine | -- | Nature Biotechnology |
| Abbott Launches PediaSure SideKicks® Clear for Picky Eaters | May 16, 2012 | Pharma News - PR Newswire |
| Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy | May 15, 2012 | Pharma News - PR Newswire |
| A strike against sales-rep OT as Lilly, Abbott win appeal | May 10, 2012 | FiercePharma |
| Abbott Laboratories Escapes a Long-Running Consent Decree | May 10, 2012 | BioSpace - Breaking News |
| Eli Lilly and Company and Abbott Laboratories Win Big in Sales Rep Overtime Case | May 10, 2012 | BioSpace - Breaking News |
| Abbott Laboratories's Humira Could Have Been a Pfizer Inc. Drug | May 09, 2012 | BioSpace - Featured Stories |
| Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Now Available in Canada | May 09, 2012 | Biotech News - PR Newswire |
| Idaho getting $1.2 million in Abbott settlement | May 08, 2012 | Health News - CNBC |
| Nebraska to get nearly $5M in Abbott settlements | May 08, 2012 | Health News - CNBC |
| Florida to receive $5M from Abbott Laboratories settlement | May 08, 2012 | Health News - BizJournals.com |
| Hawaii to receive $1.2M in Abbott Laboratories settlement | May 08, 2012 | Health News - BizJournals.com |
| Wash. to get $7 million in Abbott settlement | May 08, 2012 | Health News - CNBC |
| Ohio to get $14.5 million in Abbott settlements | May 08, 2012 | Health News - CNBC |
| Iowa will get $1.4 million in Abbott settlement | May 08, 2012 | Health News - CNBC |
| <b>Grant & Eisenhofer</b> Represents Lead Whistleblower in Historic $1.6 Billion Settlement With Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote | May 08, 2012 | BioSpace |
| Abbott Settles Depakote Allegations | May 08, 2012 | Contract Pharma |
| Abbott Laboratories to pay $1.6B in settlement | May 08, 2012 | Health News - BizJournals.com |
| Abbott Laboraties to pay $1.6B in settlement | May 08, 2012 | Health News - BizJournals.com |
| Texas to get nearly $20M in Abbott Laboratories settlement | May 08, 2012 | Health News - BizJournals.com |
| Abbott to pay $1.6B to wrap up Depakote marketing probe | May 07, 2012 | FiercePharma |
| Missouri, Illinois to receive millions in Abbott drug settlement | May 07, 2012 | Health News - BizJournals.com |
| Abbott Labs in $1.5B settlement over Depakote | May 07, 2012 | Health News - BizJournals.com |
| Colorado to receive $1.7M from Abbott settlement | May 07, 2012 | Health News - BizJournals.com |
| Ohio part of $100M Abbott Lab's settlement | May 07, 2012 | Health News - BizJournals.com |
| Abbott to pay $1.6B settlement in Depakote case | May 07, 2012 | Health News - BizJournals.com |
| Abbott Labs to pay $100M in settlement with states | May 07, 2012 | Health News - BizJournals.com |
| Minnesota Connected to Abbott Labs’ Payment of $1.5 Billion to the Government in Fraud Case | May 07, 2012 | FDA News - Business Wire |
| Abbott to Pay $1.6 Billion Over Illegal Marketing | May 07, 2012 | New York Times- Pharmaceuticals |
| Abbott to Pay $1.6 Billion in Criminal Sales Settlement | May 07, 2012 | Health News - CNBC |
| Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote | May 07, 2012 | Pharma News - PR Newswire |
| New Products from Abbott's EAS® Sports Nutrition Brand Help Athletes Improve Post-Workout Recovery and Meet Fitness Goals | April 25, 2012 | Pharma News - PR Newswire |
| Pfizer, J&J, Abbott facing shortages of crucial ingredients in Pakistan | April 24, 2012 | FiercePharma Manufacturing |
| St. Jude Medical, Abbott Laboratories expand marketing partnership | April 23, 2012 | Health News - BizJournals.com |
| Abbott and St. Jude Medical Broaden Alliance for Cardiovascular Products in the United States | April 23, 2012 | FDA News - Business Wire |
| Abbott Presents Positive Results from Phase 2 "Pilot" Study of an Interferon-Free Combination Regimen for the Treatment of Hepatitis C | April 19, 2012 | Pharma News - PR Newswire |
| Abbott Laboratories Reports Two Hepatitis C Relapses in "Pilot" Trial | April 19, 2012 | BioSpace - Breaking News |
| Abbott Presents Positive Results from Interferon-Free Phase 2 | April 19, 2012 | Pharma News - PharmiWeb |
| Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C | April 19, 2012 | Biotech News - PR Newswire |
| Abbott touts positive Parkinson's Phase III as pharma split looms | April 18, 2012 | FierceBiotech |
| Humira sales leap helps power Abbott earnings | April 18, 2012 | FiercePharma |
| Abbott Laboratories Says Breakup Plans On Target as Profit Tops Estimates | April 18, 2012 | BioSpace - Breaking News |
| Abbott Laboratories Reports Positive Phase III Study Data For Parkinson's Disease Gel | April 18, 2012 | BioSpace - Breaking News |
| Financial Reports: Abbott 1Q | April 18, 2012 | Contract Pharma |
| Abbott Reports Double-Digit Ongoing Earnings-Per-Share Growth in First Quarter; Raises Full-Year 2012 Outlook | April 18, 2012 | Pharma News - PR Newswire |
| Abbott's Investigational Treatment for Advanced Parkinson's Disease Demonstrates Positive Results in Phase 3 Clinical Trial | April 17, 2012 | Pharma News - PR Newswire |
| Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer | April 17, 2012 | Pharma News - PR Newswire |
| Abbott Achieves CE Mark for PLEX-ID Microbial Identification Technology, Assays | March 30, 2012 | Inside Industry - Gen |
| Abbott Achieves CE Mark for PLEX-ID Microbial Identification Platform and Assays | March 30, 2012 | Inside Industry - Gen |
| Abbott's PLEX-ID Molecular System and Tests for Broad Microbial Identification Obtain CE Marking | March 30, 2012 | Pharma News - PR Newswire |
| Ohio approves $1.5M loan for Abbott Laboratories plant | March 26, 2012 | Health News - BizJournals.com |
| CER Research Responds to Abbott Laboratories on China Infant Formula Report | March 23, 2012 | Medical Pharma - PR Newswire |
| Condom Found in Abbott Laboratories Infant Formula | March 21, 2012 | BioSpace - Breaking News |
| Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company | March 21, 2012 | Biotech News - PR Newswire |
| Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012 | March 20, 2012 | Biotech News - PR Newswire |
| Deals Worth $1.75 Billion Offer Insight into Abbott Laboratories's Spinoff Strategy | March 19, 2012 | BioSpace - Breaking News |
| Abbott execs take pay cuts, but White still nabs $24M | March 19, 2012 | FiercePharma |
| Abbott Laboratories CEO, Execs See Pay Cut; Pfizer Inc.'s Chief s Pay Triples First Year on Job | March 16, 2012 | BioSpace - Breaking News |
| Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance | March 08, 2012 | Pharma News - PR Newswire |
| Abbott Labs says FDA approves new stent | March 07, 2012 | Health News - CNBC |
| Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease | March 07, 2012 | Pharma News - PR Newswire |
| Abbott to Present at Barclays Capital 2012 Global Healthcare Conference | March 07, 2012 | Pharma News - PR Newswire |
| Teva selling generic for Abbott low progesterone drug Prometrium | March 02, 2012 | Health News - BizJournals.com |
| Abbott's STARLIMS Business Acquires Distribution Partners to Build International Presence | March 02, 2012 | Pharma News - PR Newswire |
| Abbott to spend $270M on Ohio nutritional plant | March 01, 2012 | Health News - CNBC |
| Abbott Nutrition to Build Nutrition Manufacturing Facility in Ohio | March 01, 2012 | BioSpace - Breaking News |
| Abbott Laboratories to Pay Galapagos NV Up to $1.35 Billion for Arthritis Drug | February 29, 2012 | BioSpace |
| Abbott's deal-team delivers $1.35B Galapagos RA pact | February 29, 2012 | FierceBiotech |
| Abbott and Galapagos Announce Global Collaboration for Novel Oral Therapy, GLPG0634, in Phase II to Treat Autoimmune Diseases | February 29, 2012 | Biotech News - PR Newswire |
| Abbott Collaborates with Leading U.S. Forensics Center on Human Identification Testing | February 23, 2012 | Biotech News - PR Newswire |
| Abbott to Present at Cowen and Company 32nd Annual Health Care Conference | February 23, 2012 | Pharma News - PR Newswire |
| Abbott prevails as Supremes pass on J&J patent suit | February 22, 2012 | FiercePharma |
| Supreme Court Rejects Johnson & Johnson's Lawsuit Over Abbott Laboratories's Humira | February 22, 2012 | BioSpace - Breaking News |
| Abbott Laboratories Faces More Investigations, Lawsuits Over Depakote Marketing | February 22, 2012 | BioSpace - Breaking News |
| Supreme Court won't review J&J-Abbott patent case | February 21, 2012 | Health News - CNBC |
| Abbott Announces 40th Consecutive Annual Increase in Quarterly Dividend | February 17, 2012 | Pharma News - PharmiWeb |
| Study Shows Abbott Laboratories's Tacrolimus Assay Demonstrates Consistent Organ Transplant Drug Monitoring | February 14, 2012 | BioSpace - Breaking News |
| Study Shows Abbott's Tacrolimus Assay Demonstrates Consistent Organ Transplant Drug Monitoring | February 13, 2012 | Pharma News - PR Newswire |
| Abbott Creates New Similac SimplySmart™ Baby Bottle with Innovative Features | February 08, 2012 | Pharma News - PR Newswire |
| Abbott to Present at Leerink Swann 2012 Global Healthcare Conference | February 01, 2012 | Pharma News - PR Newswire |
| Thermo Fisher Scientific PCT Assay for Sepsis Available for Abbott Analyzers | January 30, 2012 | Biotech News - Business Wire |
| DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases | January 30, 2012 | Pharma News - PR Newswire |
| Humira drives Abbott Q4 results | January 27, 2012 | Pharmaceutical - Moreover |
| Abbott Laboratories Cuts 700 Jobs, Even as Profits Rise | January 26, 2012 | BioSpace |
| Abbott Labs to eliminate 700 jobs | January 26, 2012 | Health News - BizJournals.com |
| Abbott strong as it prepares for spin-out | January 26, 2012 | Pharmaceutical - Moreover |
| Humira sales boost Abbott fourth-quarter figures again | January 26, 2012 | Pharmaceutical - Moreover |
| Abbott cuts 700 jobs from device and testing unit | January 26, 2012 | Pharmaceutical - Moreover |
| Abbott Labs To Lay Off Close to 700Big Impact At Vascular Stent Manufacturing Plant in Temecula, California | January 26, 2012 | Pharmaceutical - Moreover |
| Abbott Profit Rises 12%, Topping Forecasts | January 25, 2012 | Pharmaceutical - Moreover |
| Abbott rides Humira to beat estimates | January 25, 2012 | Pharmaceutical - Moreover |
| Abbott includes manufacturing in 700 job cuts | January 25, 2012 | FiercePharma Manufacturing |
| Abbott Labs cuts 700 jobs amid drop in heart stent orders, posts higher 4Q profit | January 25, 2012 | Pharmaceutical - Moreover |
| Earnings Preview: Abbott Labs reports 4Q results | January 23, 2012 | Health News - CNBC |
| Abbott's STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories | January 18, 2012 | Pharma News - PR Newswire |
| Abbott dodges excise tax at Indian plant | January 16, 2012 | FiercePharma Manufacturing |
| Abbott Laboratories: A Good Dividend Stock To Buy At $48-$52 | January 16, 2012 | Pharmaceutical - Moreover |
| Pfizer gains ground in India, but Abbott still rules | January 05, 2012 | FiercePharma |
| Abbott Biotech Ventures Invests in NeuroGenetic Pharmaceuticals | January 04, 2012 | Inside Industry - Gen |
| Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2011 Earnings | January 04, 2012 | Pharma News - PR Newswire |
| Emergent BioSolutions looks beyond deal with Abbott Laboratories | January 04, 2012 | Health News - BizJournals.com |
| The upside of Abbott cutting ties with Emergent BioSolutions | January 03, 2012 | Health News - BizJournals.com |
| Abbott Laboratories to End Venture With Emergent BioSolutions on Cancer Drug | December 29, 2011 | BioSpace |
| Abbott nixes cancer drug alliance with Emergent BioSolutions | December 29, 2011 | FierceBiotech |
| Abbott setback hits Emergent beyond just revenue | December 28, 2011 | Health News - BizJournals.com |
| Abbott ends drug development deal with Emergent Biosolutions | December 28, 2011 | Health News - BizJournals.com |
| Abbott to finalise name change | December 28, 2011 | Pharmaceutical - Moreover |
| Abbott Initiates Clinical Trial to Study Drug Eluting Bioresorbable Therapy for Treatment of Peripheral Artery Disease | December 22, 2011 | Pharma News - PR Newswire |
| Abbott and University of Illinois Establish Center for Nutrition, Learning and Memory | December 19, 2011 | Pharma News - PR Newswire |
| Abbott India’s Coming Of Age | December 17, 2011 | Pharmaceutical - Moreover |
| Abbott Licenses Reata Pipeline for $400M | December 16, 2011 | Burrill Report |
| Abbott Labs spent $890,000 on lobbying | December 15, 2011 | Health News - CNBC |
| Low diagnostics rate, Nutrition are the focus areas: Abbott India | December 15, 2011 | Pharmaceutical - Moreover |
| Abbott Labs Spinoff Looks Like the Right Move | December 13, 2011 | Pharmaceutical - Moreover |
| Reata, Abbott reach $400 million drug deal | December 13, 2011 | Health News - BizJournals.com |
| J&J, Abbott Labs and Allergan Among Wells Fargo’s Heaviest Healthcare Stock Holdings | December 13, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories Spends $400 Million on Reata Pharmaceuticals, Inc. Development Deal | December 12, 2011 | BioSpace |
| UPDATED: Abbott bets $400M on mega-blockbuster future for Reata program | December 12, 2011 | FierceBiotech |
| Abbott bets $400M on mega-blockbuster future for Reata program | December 12, 2011 | FierceBiotech |
| Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Next-Generation Antioxidant Inflammation Modulators | December 12, 2011 | Biotech News - PR Newswire |
| Crista Huff: Abbott Stock Set for Surgical Split | December 10, 2011 | Pharmaceutical - Moreover |
| Abbott Declares 352nd Consecutive Quarterly Dividend | December 09, 2011 | Pharma News - PharmiWeb |
| The Zacks Analyst Blog Highlights: Pfizer, Bristol - Myers Squibb, Eli Lilly, Forest Laboratories and Abbott Laboratories | December 08, 2011 | Pharma News - PR Newswire |
| Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent | December 08, 2011 | Biotech News - PR Newswire |
| Abbott chief says biopharma ops not for sale (at bargain price) | December 05, 2011 | FierceBiotech |
| Abbott Laboratories Dismisses Talk of Selling Pharma Unit | December 05, 2011 | BioSpace - Breaking News |
| Abbott CEO: Pharma unit not for sale | December 05, 2011 | FiercePharma |
| Abbott CEO dismisses talk of pharmaceutical unit sale | December 05, 2011 | Pharmaceutical - Moreover |
| The Law Firm of Levi & Korsinsky Launches an Investigation Into Possible Breaches of Fiduciary Duties and Unjust Enrichment by the Board of Directors of Abbott Laboratories, Inc. | December 02, 2011 | Pharma News - PR Newswire |
| Twitter alum Michael Abbott joins Kleiner Perkins | December 01, 2011 | Health News - CNBC |
| Abbott Receives FDA Clearance for New Test to Detect Vitamin D Levels | November 30, 2011 | Pharma News - PR Newswire |
| Abbott Molecular, Inc. Expands Agreement With GlaxoSmithKline to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen | November 28, 2011 | BioSpace - Breaking News |
| Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen | November 28, 2011 | Medical Pharma - PR Newswire |
| Philly Judge Sides With Abbott Laboratories on Overtime | November 23, 2011 | BioSpace |
| Philly Judge Sides With Abbott Laboratories on Overtime
| November 23, 2011 | BioSpace |
| Abbott Introduces the First FDA-Approved Supplemental Blood Test for Chagas Disease | November 21, 2011 | Pharma News - PR Newswire |
| Ex-Abbott Drug Rep Exempt From OT, Judge Says | November 17, 2011 | Pharmaceutical - Moreover |
| Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011 | November 15, 2011 | Pharma News - PR Newswire |
| New Data Reinforce Clinical Performance of Abbott's ABSORB Bioresorbable Vascular Scaffold | November 14, 2011 | Pharma News - PR Newswire |
| Cramer: Five Reason to Own Abbott Labs | November 11, 2011 | Health News - CNBC |
| Abbott Laboratories's Cholesterol Drug May Not Lower Heart Risks | November 10, 2011 | BioSpace - Breaking News |
| Abbott Laboratories Reports Five-Year Data for HUMIRA(R) (Adalimumab) in Ankylosing Spondylitis | November 08, 2011 | BioSpace - Breaking News |
| Abbott Reports Five-Year Data for HUMIRA® (Adalimumab) in Ankylosing Spondylitis | November 08, 2011 | Biotech News - PR Newswire |
| Abbott Laboratories Announces New Long-Term Data Evaluating Use of HUMIRA(R) (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA | November 07, 2011 | BioSpace - Breaking News |
| Abbott Presents HUMIRA® (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis | November 07, 2011 | Pharma News - PR Newswire |
| Abbott Announces New Long-Term Data Evaluating Use of HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA | November 06, 2011 | Pharma News - PR Newswire |
| Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility | November 04, 2011 | Biotech News - PR Newswire |
| PATH, Abbott and the Abbott Fund Form Innovative Partnership to Prevent Malnutrition | November 03, 2011 | Biotech News - PR Newswire |
| Abbott to Present New Data for Key Vascular Products at TCT 2011 | November 03, 2011 | Pharma News - PR Newswire |
| Abbott to Present at 2011 Credit Suisse Annual Health Care Conference | November 02, 2011 | Pharma News - PR Newswire |
| Abbott to Present Broad Spectrum of Compelling Data for HUMIRA® (Adalimumab) at American College of Rheumatology Annual Scientific Meeting | November 02, 2011 | Pharma News - PR Newswire |
| Experts Report that Abbott's New PLEX-ID Assay Offers Important Testing Capabilities for Biothreat Defense | November 02, 2011 | Pharma News - PR Newswire |
| Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent | November 01, 2011 | Biotech News - PR Newswire |
| FDA OKs Expanded Label of Abbott Laboratories's Treatment for Premature Puberty | October 31, 2011 | BioSpace |
| Abbott Launches Glucerna® Hunger Smart™ Nutrition Products for People with Diabetes | October 27, 2011 | Pharma News - PR Newswire |
| Dividend Star Abbott Labs Splitting Into Two Companies: We Like the Decision | October 27, 2011 | Pharmaceutical - Moreover |
| Abbott to Split into Medical-Products and Pharmaceuticals Companies | October 27, 2011 | Pharmaceutical - Moreover |
| Abbott does the two-step | October 26, 2011 | Pharmaceutical - Moreover |
| Eli Lilly and Company Not Interested in Buying Parts of Abbott Laboratories | October 25, 2011 | BioSpace |
| Abbott Awards CFCareForward Scholarships to Two Students Living With Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees | October 25, 2011 | Pharma News - PR Newswire |
| Abbott's bit parts | October 24, 2011 | Pharmaceutical - Moreover |
| Abbott spotlights blockbuster hopefuls in pitching spinoff | October 24, 2011 | FierceBiotech |
| Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA | October 24, 2011 | Pharma News - PR Newswire |
| Abbott execs predict big growth for pharma spinoff | October 24, 2011 | FiercePharma |
| Biogen Idec, Inc. (Massachusetts) and Abbott Laboratories Present Positive Data for Daclizumab HYP from Select Phase 2B Trial at | October 24, 2011 | BioSpace |
| Abbott's off-label deal said to be $800M civil, $500M criminal | October 24, 2011 | FiercePharma |
| Abbott Honored With Asian CSR Award for Leadership in Science Education | October 24, 2011 | Pharma News - PR Newswire |
| Resumen: Biogen Idec y Abbott presentan datos positivos de Daclizumab HYP del ensayo Select de fase 2B en ECTRIMS/ACTRIMS | October 24, 2011 | Pharma News - Business Wire |
| Abbott shares to rise 10 pct before split -Barron's | October 23, 2011 | Pharmaceutical - Moreover |
| Abbott's Split Into Two Companies To Increase Shareholder Value Pleases Investors | October 23, 2011 | Pharmaceutical - Moreover |
| Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pha | October 22, 2011 | Pharmaceutical - Moreover |
| Biogen Idec und Abbott präsentieren positive Daten für Daclizumab HYP aus der Phase-IIb-Studie SELECT auf dem ECTRIMS/ACTRIMS-Kongress | October 22, 2011 | Pharma News - Business Wire |
| Samenvatting: Biogen Idec en Abbott presenteren positieve resultaten voor daclizumab HYP uit Select fase 2b onderzoek op ECTRIMS/ACTRIMS | October 22, 2011 | Pharma News - Business Wire |
| Biogen Idec et Abbott présentent les résultats positifs de l’essai SELECT de phase 2b pour le Daclizumab HYP lors du congrès ECTRIMS/ACTRIMS | October 22, 2011 | Pharma News - Business Wire |
| Riassunto: Biogen Idec e Abbott presentano i risultati positivi relativi all'esperimento di fase 2B sul Daclizumab HYP presso ECTRIMS/ACTRIMS | October 22, 2011 | Pharma News - Business Wire |
| Biogen Idec and Abbott Present Positive Data for Daclizumab HYP from Select Phase 2B Trial at ECTRIMS/ACTRIMS | October 22, 2011 | Pharma News - Business Wire |
| Abbott to Split into Two Independent Public Companies | October 21, 2011 | Burrill Report |
| Abbott says hepatitis C combo may be a blockbuster | October 21, 2011 | Health News - CNBC |
| Roche Seeks "Targeted Acquisitions," Not Abbott Laboratories-Sized Deal | October 21, 2011 | BioSpace |
| Abbott Laboratories: Split-Up Long Time Coming | October 21, 2011 | Pharmaceutical - Moreover |
| Abbott reports plan to split into two separate companies | October 21, 2011 | Pharmaceutical - Moreover |
| Abbott Labs Will Split Into 2 Units | October 20, 2011 | New York Times- Pharmaceuticals |
| Abbott Splits into Two Publicly Traded Companies | October 20, 2011 | Pharmaceutical - Moreover |
| Abbott Lab's Solomonic Dividend Decision | October 20, 2011 | Pharmaceutical - Moreover |
| Is Abbott About To Unlock Value Or Throw Out The Baby With The Bathwater? | October 20, 2011 | Pharmaceutical - Moreover |
| Could Abbott Laboratories's Drug Biz Be a Potential $54 Billion Takeover Target? | October 20, 2011 | BioSpace |
| Abbott likely to retain CMO biz after split | October 20, 2011 | Pharmaceutical - Moreover |
| Will Abbott spinoff become Big Pharma's next big M&A target? | October 20, 2011 | FierceBiotech |
| Abbott to split in two | October 20, 2011 | Pharmaceutical - Moreover |
| Companies & Markets: Abbott Laboratories Dominates the Global Bare Metal Stents Market | October 20, 2011 | Clinical Trials - Business Wire |
| Report: Abbott prescription med unit could bring $54M | October 20, 2011 | FiercePharma |
| Abbott to Separate into Two Companies | October 20, 2011 | Pharmaceutical - Moreover |
| Abbott announces plans to split, form two companies | October 20, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories to Split into Two Separate Firms | October 20, 2011 | Pharmaceutical - Moreover |
| Abbott to Separate into Two Leading Companies in Diversified M... | October 20, 2011 | Pharmaceutical - Moreover |
| Abbott to Separate into Two Companies: Diversified Medical Products and Research-Based Pharmaceuticals | October 20, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories (ABT) to Split Into 2 Companies | October 20, 2011 | Pharmaceutical - Moreover |
| Abbott Labs plans to split | October 20, 2011 | Pharmaceutical - Moreover |
| Abbott Labs Splits In Bid To Drive Growth | October 20, 2011 | Pharmaceutical - Moreover |
| Abbott to Separate into Two Leading Companies in Diversifi... | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott to Separate into Two Leading Companies in Diversified Medical P... | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott Plans to Split Into Two Companies | October 19, 2011 | New York Times- Pharmaceuticals |
| Fitch: Abbott Laboratories Announces Decision to Separate Operations | October 19, 2011 | Pharmaceutical - Moreover |
| North Chicago mayor hopes Abbott breakup isn't another Hospira | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott to split into two companies | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott Labs Will Split To Drive Growth | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories' CEO Discusses Q3 2011 Results - Earnings Call Transcript | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott Splits Into Two -- Medical Products and Pharma | October 19, 2011 | Pharmaceutical - Moreover |
| South Florida resident to lead Abbott Laboratories spinoff | October 19, 2011 | Health News - BizJournals.com |
| Abbott to separate into two leading companies | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott to Split Into Two Separate Companies, Reports Q3 Sales Rise 13 Percent | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott to split into two companies, shares rise | October 19, 2011 | Pharmaceutical - Moreover |
| Amputation May Improve Abbott Laboratories' Prognosis | October 19, 2011 | Pharmaceutical - Moreover |
| UPDATE 3-Abbott to split into two companies, shares rise | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott Announces Breakup Into Two Companies, In-Line 3Q Results | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott plots spinoff of its $18B biopharma business | October 19, 2011 | FiercePharma |
| Abbott earmarks $1.5B for off-label Depakote settlement | October 19, 2011 | FiercePharma |
| Abbott to split into two public cos. — medical devices and pharmaceuticals | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott to split, Indian arm to come under medical biz division | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories to Split Into 2 Companies | October 19, 2011 | BioSpace |
| Abbott split creates an $18B biopharma deal-maker with deep pockets | October 19, 2011 | FierceBiotech |
| Split News Overshadows Abbott Results - Analyst Blog | October 19, 2011 | Pharmaceutical - Moreover |
| Split News Overshadows Abbott Results | October 19, 2011 | Pharmaceutical - Moreover |
| UPDATE 2-Abbott to split into two companies, shares jump | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories to Split Into Two Companies | October 19, 2011 | BioSpace |
| Financial Report: Abbott 3Q11 | October 19, 2011 | Contract Pharma |
| Abbott to Split into Two Separate Companies | October 19, 2011 | Inside Industry - Gen |
| Abbott to Separate Into Two Companies Focusing on Drug Areas | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott to split into two new companies | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott plans to split into two entities | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott Labs to split into 2 companies | October 19, 2011 | Health News - BizJournals.com |
| Abbott To Spin Off Pharma Business | October 19, 2011 | Contract Pharma |
| Abbott to Split into Two Separate Research-Based Pharmaceuticals and Diversified Medical Products Companies. | October 19, 2011 | Inside Industry - Gen |
| Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals (PRN) | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott to Split Into Two | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott (ABT) to Split into Two Separate, Public Companies | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott Labs Q3 Profit Down; Plans To Separate Into Two Publicly Traded Companies | October 19, 2011 | Pharmaceutical - Moreover |
| UPDATE 1-Abbott Labs to split into two public companies | October 19, 2011 | Pharmaceutical - Moreover |
| Abbott Labs plans to split into 2 companies | October 19, 2011 | Health News - CNBC |
| Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals | October 19, 2011 | Pharma News - PR Newswire |
| Abbott Reports Strong Ongoing Third Quarter Results; Confirms Double-Digit Ongoing Earnings Growth Outlook for 2011 | October 19, 2011 | Pharma News - PR Newswire |
| Abbott's ABSORB™ Bioresorbable Vascular Scaffold Honored with Wall Street Journal Technology Innovation Award | October 17, 2011 | Pharma News - PR Newswire |
| Trust Can't Boot Abbott's Humira Patent Challenge | October 14, 2011 | Biotechnology - Moreover |
| Allos Works Toward Completion Of Merger With AMAG; Abbott rolls out U.S. clinical test. | October 11, 2011 | Pharmaceutical - Moreover |
| Neurocrine Biosciences, Inc. Receives Second Milestone Payment of $20 Million Under Abbott Laboratories Collaboration Agreement | October 05, 2011 | BioSpace - Breaking News |
| Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement | October 04, 2011 | Biotech News - PR Newswire |
| Abbott Enrolls First U.S. Patient in Global EXCEL Trial Comparing XIENCE to Coronary Artery Bypass Surgery | October 04, 2011 | Clinical Trials - PR Newswire |
| Abbott venture arm takes lead on $20M Creabilis round | October 04, 2011 | FierceBiotech |
| Pfizer, Abbott Lead Dutch Pharma Market During 2010 | September 30, 2011 | Pharmaceutical - Moreover |
| Zacks Investment Ideas feature highlights: Abbott Laboratories, American Water Works and TAL International Group | September 30, 2011 | Medical Pharma - PR Newswire |
| Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals | September 23, 2011 | Pharma News - PR Newswire |
| Abbott shares rise after analyst rates as "Buy" | September 20, 2011 | Health News - CNBC |
| Abbott Named Top Dealmaker for Fourth Consecutive Year by The Deal Awards Recognize Industry-Leading Companies That Demonstrate Effective Global Mergers and Acquisitions Strategy | September 20, 2011 | Pharmaceutical - Moreover |
| Abbott Named Top Dealmaker for Fourth Consecutive Year by The Deal | September 20, 2011 | Pharma News - PR Newswire |
| Abbott Earns 100 Percent Banned Substance Free Certification for all of its EAS® Sports Nutrition Products | September 20, 2011 | Pharma News - PR Newswire |
| Abbott M&A spree boosts emerging markets share | September 19, 2011 | FiercePharma |
| Abbott Again Recognized as One of the 'Top Employers' in the Biotech and Pharmaceutical Industry by Science Magazine (9/15/11) | September 17, 2011 | Pharmaceutical - Moreover |
| Abbott Again Recognized as One of the Top Employers in the Biotech and Pharmaceutical Industry by Science Magazine | September 16, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories (ABT) Cuts 1 | September 16, 2011 | Biotechnology - Moreover |
| Abbott Again Recognized as One of the "Top Employers" in the Biotech and Pharmaceutical Industry by Science Magazine | September 15, 2011 | Biotech News - PR Newswire |
| Abbott Declares 351st Consecutive Quarterly Dividend | September 15, 2011 | Pharma News - PR Newswire |
| Abbott Laboratories Cuts 160 Jobs, Mostly at California Plant | September 15, 2011 | BioSpace |
| Abbott Named to Working Mother Magazine's 'Best Companies' List for the Eleventh Consecutive Year | September 15, 2011 | Pharma News - PR Newswire |
| Abbott Laboratories Builds Late-Stage Drug Pipeline With Deals | September 14, 2011 | BioSpace |
| Abbott deals beef up late-stage platform of blockbuster contenders | September 14, 2011 | FierceBiotech |
| Abbott Named to the Dow Jones Sustainability Indexes for Seventh Consecutive Year in Recognition of Leading Corporate Citizenship Performance | September 08, 2011 | Pharma News - PR Newswire |
| Pfizer Inc.'s Arthritis Pill Tofacitinib Matches Abbott Laboratories's Humira in Final Studies | September 08, 2011 | BioSpace |
| Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia | September 08, 2011 | Biotech News - PR Newswire |
| Abbott exec tapped for H&P manuf. ops | September 05, 2011 | FiercePharma Manufacturing |
| Abbott taps manufacturing smarts in Haiti rebuild | August 26, 2011 | FiercePharma Manufacturing |
| MedImmune Sues Abbott Alleging Breach of Contract | August 25, 2011 | Burrill Report |
| Hospira adds former Abbott executive to board | August 18, 2011 | Pharmaceutical - Moreover |
| Hospira expands board; adds Abbott's Dempsey | August 17, 2011 | Health News - CNBC |
| Abbott two new strengths of CPP drug gets FDA nod | August 17, 2011 | Pharmaceutical - Moreover |
| Abbott Targets Teva Over Latest Simcor ANDA | August 16, 2011 | Pharmaceutical - Moreover |
| Abbott Labs says FDA approves longer-acting Lupron | August 16, 2011 | Health News - CNBC |
| Abbott Laboratories Receives FDA Approval for Two Three-Month Strengths of Lupron Depot-PED?? (leuprolide acetate for depot suspension) for the Treatment of Central Precocious Puberty (CPP) | August 16, 2011 | BioSpace - Breaking News |
| Abbott Whacks Teva With Suit Over Latest Simcor ANDA | August 16, 2011 | Pharmaceutical - Moreover |
| Abbott plans $230M manufacturing plant in China | August 16, 2011 | Health News - CNBC |
| Abbott Receives FDA Approval for Two Three-Month Strengths of Lupron Depot-PED® (leuprolide acetate for depot suspension) for the Treatment of Central Precocious Puberty (CPP) | August 16, 2011 | Medical Pharma - PR Newswire |
| Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market | August 16, 2011 | Pharma News - PR Newswire |
| Information about Abbott Laboratories: PharmaVitae Profile | August 16, 2011 | Pharmaceutical - Moreover |
| First Patient in Japan Treated with Abbott's Bioresorbable Vascular Scaffold as Part of Global Clinical Trial | August 16, 2011 | Pharma News - PR Newswire |
| Abbott Hit With 2 Suits Over Depakote Birth Defects | August 16, 2011 | Pharmaceutical - Moreover |
| Biogen, Abbott Announce Positive Trial Results for MS Drug | August 11, 2011 | Biotechnology - Moreover |
| Abbott's PediaSure® Brand Aims to Help Moms With Picky Eaters "Take Back the Table" By Building Lifelong Healthy Eating Habits | August 11, 2011 | Pharma News - PR Newswire |
| Firmy Biogen Idec a Abbott zveřejnily pozitivní výsledky prvního kola klinického hodnocení léku Daclizumab HYP u pacientů s recidivující roztroušenou sklerózou | August 11, 2011 | Pharma News - Business Wire |
| Abbott Introduces Vector-borne Pathogen Test to Detect Microorganisms Carried by Ticks and Other Insects | August 10, 2011 | Biotech News - PR Newswire |
| Abbott Receives U.S. FDA Approval for RX Herculink Elite® Renal Stent System for Treatment of Renal Artery Disease | August 10, 2011 | Medical Pharma - PR Newswire |
| Biogen Idec i Abbott ogłaszają pozytywne wyniki z pierwszych badań rejestracyjnych leku Daclizumab HYP wykorzystywanego do leczenia postaci zaostrzająco-zwalniającego stwardnienia rozsianego | August 10, 2011 | Pharma News - Business Wire |
| A Biogen Idec és az Abbott bejelentette kiújuló-lappangó szklerózis multiplex kezelésére szolgáló Daclizumab HYP első regisztrációs tesztjének sikeres lezárását | August 10, 2011 | Pharma News - Business Wire |
| Biogen Idec et Abbott annoncent d'excellents résultats pour le premier essai d’homologation du Daclizumab HYP contre la sclérose en plaques rémittente | August 10, 2011 | Pharma News - Business Wire |
| Biogen Idec und Abbott melden positive Ergebnisse der ersten Zulassungsstudie für Daclizumab HYP bei schubförmig remittierender multipler Sklerose | August 09, 2011 | Pharma News - Business Wire |
| Biogen Idec e Abbott Anunciam Resultados Operacionais Positivos do Primeiro Ensaio Clínico de Registro do Daclizumab HYP em Esclerose Múltipla Remitente-Recorrente | August 09, 2011 | Pharma News - Business Wire |
| Biogen and Abbott advance MS drug candidate | August 09, 2011 | Health News - BizJournals.com |
| Biogen Idec, Inc. (Massachusetts) and Abbott Laboratories Report Top-Line Positive Results for Daclizumab HYP Trial in RRMS | August 09, 2011 | BioSpace |
| Boston Scientific and Abbott Laboratories Lead the Global Drug Eluting Stents Market: companiesandmarkets.com | August 09, 2011 | Pharma News - Business Wire |
| Biogen, Abbott tout promising MS data from PhIIb daclizumab trial | August 09, 2011 | FierceBiotech |
| Biogen Idec and Abbott Announce Positive Top-Line Results from the First Registrational Trial for Daclizumab HYP in Relapsing-Remitting Multiple Sclerosis | August 09, 2011 | Pharma News - Business Wire |
| Biogen Idec en Abbott maken positieve top-lineresultaten bekend van het eerste registrationele onderzoek naar Daclizumab HYP bij relapsing-remitting multiple sclerose | August 09, 2011 | Pharma News - Business Wire |
| Biogen Idec e Abbott annunciano i risultati positivi della prima sperimentazione per la registrazione di Daclizumab HYP nella sclerosi multipla recidivante-remittente | August 09, 2011 | Pharma News - Business Wire |
| Biogen Idec y Abbott anuncian resultados positivos de gran calidad en el primer ensayo de registro para Daclizumab HYP en esclerosis múltiple recurrente-remitente | August 09, 2011 | Pharma News - Business Wire |
| Perdue Kidd & Vickery Files Lawsuit Against Abbott Laboratories for Inadequate Leukemia and Cancer Warning | July 29, 2011 | Pharma News - PR Newswire |
| Abbott's HIV Combo Test Detects Infections Earlier, Provides Valuable Information to Help Prevent Further HIV Transmission and May Save Treatment Costs | July 27, 2011 | Medical Pharma - PR Newswire |
| Abbott Says Nutritionals Can Succeed Without M&A Activity | July 25, 2011 | Pharmaceutical - Moreover |
| Abbott to Feature Acute HIV Diagnostic, Metabolic Function Tests and Lab Informatics at American Association for Clinical Chemistry Annual Meeting | July 21, 2011 | Pharma News - PR Newswire |
| Roche, Lilly profits drop as Abbott sales grow | July 21, 2011 | FiercePharma |
| Profits Up 50 Percent For Abbott Labs | July 20, 2011 | Pharmaceutical - Moreover |
| Summary Box: Abbott 2Q profit rises 11 percent | July 20, 2011 | Health News - CNBC |
| Abbott Labs 2Q profit grows with emerging markets | July 20, 2011 | Health News - CNBC |
| Emerging markets boost Abbott's Q2 profits | July 20, 2011 | FiercePharma |
| Earnings roundup: PNC Financial, Abbott Labs | July 20, 2011 | Health News - CNBC |
| Financial Report: Abbott 2Q | July 20, 2011 | Contract Pharma |
| Abbott Laboratories 2Q Net Up 50% As Proprietary Sales Climb, Raises Outlook | July 20, 2011 | Pharmaceutical - Moreover |
| Abbott Labs 2Q profit jumps on tax benefit | July 20, 2011 | Health News - CNBC |
| Abbott Reports 11 Percent Ongoing Earnings-Per-Share Growth in Second Quarter; Raises 2011 EPS Guidance Range | July 20, 2011 | Pharma News - PR Newswire |
| Option Players Charge Pharmaceutical Siblings Abbott Laboratories and Pfizer | July 19, 2011 | Pharmaceutical - Moreover |
| Drugs from Abbott Laboratories's Lupron and AstraZeneca PLC's Zoladex May Boost Life Expectancy for Prostate Cancer Patients | July 14, 2011 | BioSpace |
| BIOTRONIK Announces First Patients Treated in BIOFLOW-II Clinical Study Comparing ORSIRO Hybrid Drug-Eluting Stent to Abbott's XIENCE PRIME™ | July 13, 2011 | Biotech News - Business Wire |
| Abbott Labs Should Deliver, Pipeline ?Unappreciated? Says RBC | July 11, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories (ABT) Sued Over Beetles In Baby Formula | July 11, 2011 | Pharmaceutical - Moreover |
| Abbott Labs Should Deliver, Pipeline 'Unappreciated' Says RBC | July 11, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories Sued Over Beetles In Baby Formula | July 11, 2011 | BioSpace - Breaking News |
| Abbott Laboratories's Anti-HIV Drug Kaletra Can Cause Adrenal Problems in Newborns | July 06, 2011 | BioSpace |
| FDA Warns Against Abbott Laboratories's Depakote for Pregnant Women | July 01, 2011 | BioSpace |
| Will Abbott's Niaspan fall short of blockbuster sales? | June 30, 2011 | FiercePharma |
| Abbott to Fund Pharmaceutical and Diagnostics Research at the Weizmann Institute of Science | June 29, 2011 | Pharmaceutical - Moreover |
| Abbott says blood sugar monitoring devices stolen | June 24, 2011 | Health News - CNBC |
| Information Notice on Stolen Abbott Diabetes Care Blood Glucose Monitoring Products | June 24, 2011 | Pharma News - PR Newswire |
| Kidney improvement sustained by Abbott drug: study | June 24, 2011 | Health News - CNBC |
| Abbott makes $85 Million Bet on Biotest | June 23, 2011 | Burrill Report |
| Texas AG Abbott sues GSK over drugs | June 23, 2011 | Health News - BizJournals.com |
| Abbott Laboratories Plant Closure Delayed, Workers Will Get to Keep Jobs for Another Year | June 23, 2011 | BioSpace - Breaking News |
| Abbott Laboratories Plant Closure Delayed | June 23, 2011 | BioSpace |
| Abbott pushes back closure date on Canadian plant | June 23, 2011 | FiercePharma |
| Abbott diabetes gear lost in cargo theft | June 23, 2011 | FiercePharma Manufacturing |
| Abbott delays pink slips due to product demand | June 23, 2011 | FiercePharma Manufacturing |
| Abbott eyes Humira tweaks on way to No. 1 | June 22, 2011 | FiercePharma |
| Abbott Laboratories Plans Changes to Humira to Thwart Competition | June 22, 2011 | BioSpace |
| Abbott Laboratories and Biotest AG Seal $470 Million Pact Over Arthritis Drug | June 21, 2011 | BioSpace |
| Abbott inks $470M pact for Biotest's Ph2 RA antibody program | June 21, 2011 | FierceBiotech |
| Abbott and Biotest Announce Global Agreement to Develop and Commercialize Novel Antibody for Autoimmune Diseases | June 21, 2011 | Pharma News - PR Newswire |
| Abbott Receives FDA Approval For A New Six-Month Formulation Of Lupron Depot® | June 21, 2011 | Pharmaceutical - Moreover |
| FDA OKs new version of Abbott Labs cancer drug | June 20, 2011 | Health News - CNBC |
| Abbott Laboratories Receives FDA Approval for a New Six-Month Formulation of Lupron Depot(R) (leuprolide acetate for depot suspension) for the Palliative Treatment of Advanced Prostate Cancer | June 20, 2011 | BioSpace - Breaking News |
| Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot® (leuprolide acetate for depot suspension) for the Palliative Treatment of Advanced Prostate Cancer | June 20, 2011 | Pharma News - PR Newswire |
| Gateway 2011: Abbott Laboratories | June 17, 2011 | Pharmaceutical - Moreover |
| Reata Pharmaceuticals, Inc. and Abbott Laboratories Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes | June 16, 2011 | BioSpace - Breaking News |
| Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes | June 16, 2011 | Pharma News - PR Newswire |
| Abbott wins FDA approval for infant CF dose | June 15, 2011 | Pharmaceutical - Moreover |
| FDA OKs infant dose of Abbott's Creon capsules | June 14, 2011 | Pharmaceutical - Moreover |
| Abbott: FDA Approves Infant Dose Of Creon Pancreatic Enzyme | June 14, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories Receives FDA Approval for CREON?? (Pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis | June 14, 2011 | BioSpace - Breaking News |
| Humira patient accuses Abbott of 'stalling' on warning | June 14, 2011 | FiercePharma |
| Abbott Receives FDA Approval for CREON® (Pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis | June 14, 2011 | Pharma News - PR Newswire |
| Abbott Laboratories (ABT) Declares 3 | June 10, 2011 | Biotechnology - Moreover |
| Abbott Declares 350th Consecutive Quarterly Dividend | June 10, 2011 | Pharma News - PharmiWeb |
| Abbott releases early results of Parkinson's study | June 09, 2011 | Health News - CNBC |
| Abbott Laboratories Reports Interim Results From Phase III Open-Label Study of Investigational Treatment for Advanced Parkinson's Disease | June 09, 2011 | BioSpace - Breaking News |
| Abbott Reports Interim Results From Phase III Open-Label Study of Investigational Treatment for Advanced Parkinson's Disease | June 09, 2011 | Pharma News - PR Newswire |
| Abbott in talks to resolve Depakote marketing suits | June 03, 2011 | FiercePharma |
| Ekol to provide logistics operations for Abbott in Turkey | May 31, 2011 | Pharmaceutical - Moreover |
| Analysts see lower sales for Abbott's Niaspan | May 27, 2011 | Health News - CNBC |
| The Zacks Analyst Blog Highlights: Mylan, Abbott Laboratories, Ista Pharmaceuticals, Johnson & Johnson and Teva Pharmaceuticals | May 27, 2011 | Pharmaceutical - Moreover |
| Abbott down after NIH halts Niaspan study | May 26, 2011 | FiercePharma |
| Abbott Statement on Interim Study Results of AIM-HIGH | May 26, 2011 | Biotech News - PR Newswire |
| UCB Pharma To Test Arthritis Drug Cimzia Against Abbott Laboratories's Humira | May 26, 2011 | BioSpace - Breaking News |
| Abbott Laboratories (ABT) to Present at Goldman, Sachs & Co. | May 25, 2011 | Biotechnology - Moreover |
| Abbott to Present at Goldman Sachs 32nd Annual Global Healthcare Conference | May 25, 2011 | Biotech News - PR Newswire |
| Abbott Receives U.S. FDA Approval for XIENCE nano™ to Treat Coronary Artery Disease in Small Vessels | May 24, 2011 | Pharma News - PR Newswire |
| Abbott Laboratories Sued on Claims Humira Caused Permanent Eye Damage | May 24, 2011 | BioSpace |
| Abbott Completes Submission of New Molecular Test Intended for Non-small-cell Lung Cancer Therapy Selection | May 23, 2011 | Pharma News - PR Newswire |
| FDA Panel Calls for New Trial on Abbott Laboratories's Trilipix | May 20, 2011 | BioSpace |
| Abbott Introduces New ZonePerfect® Sweet & Salty Nutrition Bars | May 20, 2011 | Pharma News - PR Newswire |
| Abbott Statement on the FDA Advisory Committee Recommendations on Fenofibric Acid | May 19, 2011 | Pharma News - PR Newswire |
| FDA panel backs key use of Abbott cholesterol drug | May 19, 2011 | Health News - CNBC |
| Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay | May 18, 2011 | Pharma News - PR Newswire |
| VIDEO from Abbott and Synaptic Digital: Abbott Receives FDA Approval for Molecular Test for Hepatitis C | May 18, 2011 | Medical Pharma - PR Newswire |
| Abbott Receives FDA Approval for Molecular Test for Hepatitis C | May 18, 2011 | Pharma News - PR Newswire |
| FDA panel to weigh revoking key use of Abbott drug | May 17, 2011 | Health News - CNBC |
| Abbott's Trilipix faces loss of combo indication | May 17, 2011 | FiercePharma |
| FDA Weighs Revoking Approval Of Abbott Laboratories's Trilipix | May 17, 2011 | BioSpace |
| Abbott drug meets ulcerative colitis study goals | May 10, 2011 | Health News - CNBC |
| Abbott Laboratories' HUMIRA(R) (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study | May 10, 2011 | BioSpace |
| Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study | May 10, 2011 | Pharma News - PR Newswire |
| Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Receives CE Mark | May 10, 2011 | Pharma News - PR Newswire |
| FDA expands use of Abbott Labs' neck stent | May 06, 2011 | Health News - CNBC |
| Abbott Receives FDA Approval to Expand Use of the RX ACCULINK(R) Carotid Stent System to Patients at Standard Surgical Risk | May 06, 2011 | Pharma News - PharmiWeb |
| Abbott Receives FDA Approval to Expand Use of the RX ACCULINK® Carotid Stent System to Patients at Standard Surgical Risk | May 06, 2011 | Pharma News - PR Newswire |
| Abbott to Present at Bank of America Merrill Lynch 2011 Health Care Conference | May 03, 2011 | Pharma News - PR Newswire |
| Krumholz questions Abbott blood-lipid drugs | May 02, 2011 | FiercePharma |
| Abbott Laboratories Cuts Cost of AIDS Drug for Government Programs | May 02, 2011 | BioSpace |
| Abbott Laboratories Receives U.S. FDA Approval for AndroGel(R) 1.62% to Treat Men with Low Testosterone | May 02, 2011 | BioSpace |
| Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone | April 29, 2011 | Biotech News - PR Newswire |
| Abbott Highlights Top-Tier Financial Performance, Strong Growth in Emerging Markets at Annual Meeting | April 29, 2011 | Pharma News - PR Newswire |
| AHF to Question Abbott on AIDS Drug Pricing During April 29 AGM in Abbott Park | April 29, 2011 | Pharma News - Business Wire |
| Abbott Laboratories and Laboratoires Fournier sign agreement with Lupin Deal In Brief | April 27, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories Sued on Claim Humira Caused Lasting Nerve Damage | April 27, 2011 | BioSpace |
| Lupin Ltd. Inks Pact with Abbott Laboratories, Fournier Pharma | April 26, 2011 | BioSpace |
| Lupin Ltd. Inks Pact withAbbott Laboratories, Fournier Pharma | April 26, 2011 | BioSpace |
| FDA Panel To Review Abbott Laboratories's Cholesterol Drug Trilipix May 19 | April 26, 2011 | BioSpace |
| <b>Abbott Japan</b> and Eisai Company, Ltd. Receive Approval to Market the Pancreatic Digestive Enzyme Replacement Drug Lipacreon(R) (pancrelipase) in Japan | April 22, 2011 | BioSpace - Breaking News |
| Abbott CEO to join American Academy of Arts and Sciences | April 21, 2011 | Pharmaceutical - Moreover |
| Abbott's earnings slide | April 21, 2011 | Pharmaceutical - Moreover |
| Abbott reports stronger sales | April 21, 2011 | Pharmaceutical - Moreover |
| Summary Box: Abbott Labs tops 1Q expectations | April 20, 2011 | Health News - CNBC |
| Abbott 1Q Profit Falls 14% On Charges Despite Sales Growth | April 20, 2011 | Pharmaceutical - Moreover |
| Abbott 1Q profit beats estimates on higher sales | April 20, 2011 | Health News - CNBC |
| Abbott Laboratories 1Q Profit Slumps on Costs | April 20, 2011 | Health News - Fox Business |
| Financial Report: Abbott 1Q11 | April 20, 2011 | Contract Pharma |
| Abbott 1Q profit falls 14 percent on charges | April 20, 2011 | Health News - CNBC |
| Abbott Reports 17.4 Percent Sales Growth and 12.3 Percent Ongoing Earnings-Per-Share Growth in First Quarter | April 20, 2011 | Pharma News - PR Newswire |
| Abbott Chairman and CEO Miles D. White Elected to the American Academy of Arts & Sciences | April 19, 2011 | Biotech News - PR Newswire |
| Earnings Preview: Abbott to report 1Q earnings | April 18, 2011 | Health News - CNBC |
| Zacks Analyst Blog Highlights: Myriad Genetics, BioMarin Pharmaceuticals, Abbott Laboratories, AstraZeneca and Sanofi-Aventis | April 08, 2011 | Pharma News - PR Newswire |
| Abbott Labs Heart Device Effective After 2 Years | April 04, 2011 | Health News - Fox Business |
| Abbott heart device durable after 2 years | April 04, 2011 | Health News - CNBC |
| Abbott Laboratories Reports Positive 12-week Results From Phase 2 Study Of Hepatitis C Drug | April 04, 2011 | BioSpace - Breaking News |
| Data From Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients With Mitral Regurgitation Two Years After Treatment | April 04, 2011 | Pharma News - PR Newswire |
| Abbott and Enanta Present Positive 12-Week Results and 3-Day Resistance Data From Phase 2 Study of ABT-450/r for Treatment of Hepatitis C | April 04, 2011 | Pharma News - PR Newswire |
| Abbott absorbable stent shows good results | April 03, 2011 | Health News - CNBC |
| Abbott's ABSORB Bioresorbable Vascular Scaffold Demonstrates Positive One-Year Safety and Efficacy Results | April 03, 2011 | Pharma News - PR Newswire |
| Jury: Abbott breached GSK deal, but not competition law | March 31, 2011 | FiercePharma |
| Abbott Introduces Hepatitis B Sequencing Test in Europe | March 31, 2011 | Pharma News - PR Newswire |
| U.S. Jury Rejects GlaxoSmithKline Antitrust Claims vs Abbott Laboratories | March 31, 2011 | BioSpace |
| Abbott Announces Launch of Catheter-Based MitraClip® System in Australia for Mitral Regurgitation, the Most Common Heart Valve Condition | March 30, 2011 | Pharma News - PR Newswire |
| Abbott Labs gets approval for wireless test device | March 29, 2011 | Health News - CNBC |
| FDA Clears Abbott's i-STAT® 1 Wireless Point of Care Testing System | March 29, 2011 | Medical Pharma - PR Newswire |
| Pharmaceutical and Research: Reports from Abbott Laboratories Describe Recent Advances in Pharmaceutical and Research | March 29, 2011 | Pharmaceutical - Moreover |
| Abbott Introduces Micro-Implantation Cataract Suite | March 28, 2011 | Pharma News - PR Newswire |
| Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011 | March 28, 2011 | Biotech News - PR Newswire |
| Jurors debate in GSK-Abbott drug-pricing dispute | March 25, 2011 | FiercePharma |
| Abbott Laboratories Settles HIV Pricing Claims with Pharmacies | March 24, 2011 | BioSpace |
| SeaGen Strikes Abbott Deal, Omeros Passes Study, Alnylam Fires Back at Tekmira, & More Seattle-Area Life Sciences News | March 24, 2011 | Xconomy Life Sciences |
| Abbott Files New Simcor Patent Suit Against Teva | March 23, 2011 | Pharmaceutical - Moreover |
| Seattle Genetics, Inc. Announces Antibody-Drug Conjugate Collaboration with Abbott Laboratories; Gets $8 Million Upfront; Eligible for as much as $200 Million | March 22, 2011 | BioSpace |
| SeaGen Inks Abbott Deal | March 22, 2011 | Xconomy Life Sciences |
| Abbott's New HIV-1 Qualitative Assay Improves Testing Access in Remote Areas for Children and Adults | March 21, 2011 | Biotech News - PR Newswire |
| Depomed, Inc. Pockets $40 Million as Abbott Laboratories Returns Gralise Rights | March 18, 2011 | BioSpace |
| Price of Abbott's Epilepsy Drug Revised | March 18, 2011 | Pharmaceutical - Moreover |
| Depomed regains rights to Gralise from Abbott Labs | March 17, 2011 | Health News - CNBC |
| Abbott's White sees bonus, stock awards slip | March 16, 2011 | FiercePharma |
| Abbott Laboratories CEO compensation drops 8 pct | March 16, 2011 | Health News - CNBC |
| Abbott Laboratories CEO's Total Compensation Slipped 2.5% In 2010
| March 16, 2011 | BioSpace |
| Abbott Supports Relief Efforts in Japan | March 14, 2011 | Pharma News - PR Newswire |
| Zacks Bull and Bear of the Day Highlights: Trinity Biotech, HDFC Bank, Ltd. - ADS, Endo Pharmaceuticals, Johnson & Johnson and Abbott Laboratories | March 09, 2011 | Medical Pharma - PR Newswire |
| Positive Results from Phase 2 Study of Abbott Laboratories's Atrasentan for Treatment of Diabetic Kidney Disease Published in the Journal of the American Society of Nephrology | March 04, 2011 | BioSpace |
| Abbott: Kaletra HIV med 'clobbered' by rivals | March 02, 2011 | FiercePharma |
| Abbott to Present at Barclays Capital 2011 Global Healthcare Conference | March 01, 2011 | Pharma News - PR Newswire |
| Abbott Products pays $48m milestone to Depomed | March 01, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories (ABT) Wins Reversal of Johnson & Johnson (JNJ)’s $1. | February 25, 2011 | Biotechnology - Moreover |
| Abbott Laboratories Wins Reversal of Johnson & Johnson???s $1.67 Billion Patent Victory | February 24, 2011 | BioSpace |
| Abbott wins $1.7bn Humira case | February 24, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories (ABT) Reworks Pharma Ops As Head Of US Unit Retires; Will Combine American and International Patented-drug Businesses Into One Organization | February 23, 2011 | Pharmaceutical - Moreover |
| Abbott wins appeal of Humira patent enfringement | February 23, 2011 | Biotechnology - Moreover |
| Abbott wins reversal of Humira patent judgment | February 23, 2011 | Health News - CNBC |
| Abbott Laboratories Reworks Pharma Ops As Head Of US Unit Retires; Will Combine American and International Patented-drug Businesses Into One Organization | February 23, 2011 | BioSpace |
| Abbott merges U.S., foreign pharma units under new chief | February 23, 2011 | FiercePharma |
| Abbott announces plans to combine American, international patented drug businesses | February 23, 2011 | Pharmaceutical - Moreover |
| CORRECT: Abbott Reworks Pharma Operations As Head Of US Unit Retires | February 23, 2011 | Pharmaceutical - Moreover |
| Abbott Reworks Pharma Operations As Head Of US Unit Retires | February 23, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories (ABT) to Present at Cowen and Company | February 23, 2011 | Biotechnology - Moreover |
| UPDATE: Abbott Reworks Pharma Operations As Head Of US Unit Retires | February 23, 2011 | Pharmaceutical - Moreover |
| Abbott Reorganizes Pharma Operations As Head Of US Unit Retires | February 22, 2011 | Pharmaceutical - Moreover |
| Abbott to Present at Cowen and Company 31st Annual Health Care Conference | February 22, 2011 | Pharma News - PR Newswire |
| US Abbott plans to downsize workforce in France | February 18, 2011 | Pharmaceutical - Moreover |
| Abbott Labs Boosts Quarterly Dividend 9.1% To 48 Cents | February 18, 2011 | Pharmaceutical - Moreover |
| Abbott board raises dividend 9 percent | February 18, 2011 | Health News - CNBC |
| Abbott Announces Increase in Quarterly Dividend | February 18, 2011 | Pharma News - PR Newswire |
| Abbott distribution 2011 | February 17, 2011 | Pharmaceutical - Moreover |
| Abbott to Present at RBC Capital Markets' Healthcare Conference | February 15, 2011 | Biotech News - PR Newswire |
| Abbott's Ibis Technology Identified Fatal Disease Organism in Afghanistan | February 07, 2011 | Pharma News - PR Newswire |
| Abbott Introduces Biothreat Assay for PLEX-ID™ System | February 07, 2011 | Biotech News - PR Newswire |
| DoJ adds weight to Abbott whistleblower suit | February 07, 2011 | FiercePharma |
| Will Abbott end up marketing Depomed's Gralise? | February 01, 2011 | FiercePharma |
| Abbott's TREK® Coronary Balloon System Now Available in the United States and Japan | January 31, 2011 | Pharma News - PR Newswire |
| Recently released market study: Abbott Laboratories: PharmaVitae Profile | January 29, 2011 | Pharmaceutical - Moreover |
| Pharmaceutical Companies Like Abbott Laboratories (ABT) Cutting Jobs In Wake of Health Care Reform | January 28, 2011 | Pharmaceutical - Moreover |
| Pharmaceutical Companies Like Abbott Laboratories Cutting Jobs In Wake of Health Care Reform | January 28, 2011 | BioSpace - Featured Stories |
| Abbott to eliminate 1,900 employees | January 27, 2011 | Pharmaceutical - Moreover |
| Abbott will reduce its pharmaceutical staff | January 27, 2011 | Pharmaceutical - Moreover |
| Abbott Reports Q4 Earnings Growth | January 27, 2011 | Pharmaceutical - Moreover |
| Abbott jobs axe hits manufacturing | January 27, 2011 | FiercePharma Manufacturing |
| Abbott to cut 1,900 US employees | January 27, 2011 | Pharmaceutical - Moreover |
| Abbott plans to "streamline" US pharma business as it reports strong Q4 | January 27, 2011 | Pharmaceutical - Moreover |
| Abbott Laboratories' 4th-quarter profit falls 6 percent on buyout costs, but matches forecast | January 27, 2011 | Pharmaceutical - Moreover |
| Abbott to cut 1,900 jobs amid 'significant headwinds' | January 26, 2011 | Pharmaceutical - Moreover |
| U.S. panel backs Abbott carotid stent for more patients | January 26, 2011 | Health News - CNBC |
| FDA panel backs wider use of Abbott Labs stent | January 26, 2011 | Health News - CNBC |
| FDA Advisory Committee Votes Favorably on Expanding the Indication for Abbott's Carotid Stent System to Include Patients at Standard Surgical Risk | January 26, 2011 | Pharma News - PR Newswire |
| Summary Box: Abbott cuts work force by 2 percent | January 26, 2011 | Health News - CNBC |
| Abbott reports strong Q4 but set to "streamline" US pharma business | January 26, 2011 | Pharmaceutical - Moreover |
| Abbott Labs 4Q Profit Climbs 10%, Shares Slip on Outlook | January 26, 2011 | Health News - Fox Business |
| Abbott net earnings down 6.4% in Q4 | January 26, 2011 | Pharmaceutical - Moreover |
| Abbott To Cut 2% Of Work Force, 4Q Net Falls 6.4% | January 26, 2011 | Health News - Fox Business |
| Abbott dips as drug indexes inch higher | January 26, 2011 | Biotechnology - Moreover |
| Abbott Laboratories (ABT) Cuts 1,9 | January 26, 2011 | Biotechnology - Moreover |
| Abbott cuts 1,900 jobs from US drug business | January 26, 2011 | Health News - CNBC |
| Abbott Beats Forecats, but Profit Falls on Buyout Costs | January 26, 2011 | Health News - CNBC |
| Abbott Laboratories Beats Forecasts as Drug Sales Shine | January 26, 2011 | BioSpace |
| Abbott Laboratories Cuts 1,900 Jobs in Restructuring of Drug Unit, Reports Lower Net | January 26, 2011 | BioSpace |
| Abbott to axe another 1,900 jobs | January 26, 2011 | FiercePharma |
| Abbott earnings dip on restructuring, acquisitions | January 26, 2011 | Pharmaceutical - Moreover |
| Abbott 4Q Net Down 6.4% On Higher Charges, Masking Higher Revenue | January 26, 2011 | Pharmaceutical - Moreover |
| Abbott 4Q profit falls 6 percent on buyout costs | January 26, 2011 | Health News - CNBC |
| Abbott Beats Forecasts as Drug Sales Shine | January 26, 2011 | Health News - CNBC |
| Abbott Net Income Falls 6%, Adjusted Net Hits Mark | January 26, 2011 | Health News - Fox Business |
| Abbott chops 1,900 workers after experimental drugs flop | January 26, 2011 | FierceBiotech |
| Abbott Reports Q4 EPS of $1.30 vs. $1.29 | January 26, 2011 | Pharmaceutical - Moreover |
| Abbott Reports Double-Digit Sales and Ongoing Earnings Growth in Fourth Quarter; Issues Strong Ongoing Earnings Outlook for 2011 | January 26, 2011 | Medical Pharma - PR Newswire |
| Intelligent Medical Devices (IMDx) signs agreement with Abbott Laboratories | January 21, 2011 | Pharmaceutical - Moreover |
| Intelligent Medical Devices, Inc. (IMDx) Enters into an Agreement with Abbott for the Distribution of a Broad Menu of Molecular Tests | January 20, 2011 | Biotech News - PR Newswire |
| Depomed, Inc. Falls on Abbott Laboratories's Reluctance to Market Pain Drug, Will Engage in Mediation to Resolve Dispute | January 19, 2011 | BioSpace |
| Abbott Withdraws MAA for Ozespa | January 17, 2011 | Contract Pharma |
| Abbott Withdraws Marketing Authorization Application For Ozespa | January 17, 2011 | Health News - Fox Business |
| Abbott Labs pulls application for psoriasis drug | January 14, 2011 | Health News - CNBC |
| UPDATE 2-Abbott withdraws applications for psoriasis drug | January 14, 2011 | Biotechnology - Moreover |
| Abbott Withdraws US, European Applications For Psoriasis Drug | January 14, 2011 | Health News - Fox Business |
| Daley resigns from Boeing, Abbott boards | January 10, 2011 | Health News - CNBC |
| Abbott to launch first absorbable stent in Europe | January 10, 2011 | Health News - CNBC |
| Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease | January 10, 2011 | Pharma News - PR Newswire |
| Partners In Health, Abbott and the Abbott Fund Unite to Combat Severe Childhood Malnutrition in Haiti | January 07, 2011 | Pharma News - PR Newswire |
| Patent office rejects Abbott's HIV drug application | January 04, 2011 | Pharmaceutical - Moreover |
| Abbott lobbying budget rises to $910,000 in 3Q | January 04, 2011 | Health News - CNBC |
| Abbott Laboratories' Kaletra HIV-Drug Patent Rejected in India, Allowing Cipla Ltd. Copies | January 04, 2011 | BioSpace |
| Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2010 Earnings | January 03, 2011 | Pharma News - PR Newswire |
| Glucose test strip age may be behind Abbott recall | December 29, 2010 | FiercePharma Manufacturing |
| AstraZeneca, Abbott End Heart Drug, Certriad Pact | December 27, 2010 | Pharmaceutical - Moreover |
| AstraZeneca PLC (AZN), Abbott Laboratories (ABT) End Heart Drug, Certriad Pact | December 27, 2010 | Biotechnology - Moreover |
| AstraZeneca PLC, Abbott Laboratories End Heart Drug, Certriad Pact | December 27, 2010 | BioSpace |
| Abbott buys Piramal's pharma arm for $3.7bn | | December 26, 2010 | Pharmaceutical - Moreover |
| AstraZeneca and Abbott Pull NDA for Lipidemia Drug | December 23, 2010 | Inside Industry - Gen |
| AstraZeneca, Abbott Kill Co-Development Deal Early | December 23, 2010 | Health News - Fox Business |
| AZ, Abbott dump heart drug | December 23, 2010 | FierceBiotech |
| AstraZeneca, Abbott End Drug-license Deal | December 23, 2010 | Health News - Fox Business |
| AstraZeneca, Abbott End Certriad License Deal | December 22, 2010 | Health News - Fox Business |
| Abbott and AstraZeneca End License Agreement for the Development of CERTRIAD™ | December 22, 2010 | Pharma News - PR Newswire |
| AstraZeneca and Abbott End License Agreement for the Development of CERTRIAD | December 22, 2010 | Biotech News - PR Newswire |
| Abbott Recalls About 359 Million Blood Testing Strips | December 22, 2010 | Health News - Fox Business |
| Abbott recalls millions of diabetes testing strips | December 22, 2010 | Health News - CNBC |
| PRESS RELEASE: FDA Announces Recall of Abbott Glucose Test Strips | December 22, 2010 | Health News - Fox Business |
| Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico | December 22, 2010 | Pharma News - PR Newswire |
| FDA announces recall of Abbott glucose test strips | December 22, 2010 | FDA Press Releases |
| EpiTherapeutics and Abbott Laboratories Enter Into Oncology Collaboration on Epigenetic Targets | December 20, 2010 | BioSpace - Breaking News |
| EpiTherapeutics and Abbott Enter Into Oncology Collaboration on Epigenetic Targets | December 20, 2010 | Medical Pharma - PR Newswire |
| Research and Markets: Abbott Laboratories - SWOT Framework Analysis | December 15, 2010 | Pharma News - Business Wire |
| Abbott board declares 44 cent quarterly dividend | December 10, 2010 | Health News - CNBC |
| Abbott Declares 348th Consecutive Quarterly Dividend | December 10, 2010 | Biotech News - PR Newswire |
| Caterpillar adds IBM, Abbott Labs execs to board | December 09, 2010 | Health News - CNBC |
| Abbott among top supply chain innovators of all time | December 09, 2010 | FiercePharma Manufacturing |
| Drug Companies Abbott Laboratories, B.Braun Medical and Roxane Laboratories, Inc., Paying $421 Million to Settle Government Case | December 08, 2010 | BioSpace |
| Abbott Laboratories (ABT) Subsidiary Kos Pharmaceuticals (KOSP) Reaches $ | December 08, 2010 | Biotechnology - Moreover |
| Abbott Laboratories Subsidiary Kos Pharmaceuticals Reaches $41M Settlement | December 08, 2010 | BioSpace |
| Abbott subsidiary reaches $41M settlement | December 08, 2010 | Health News - CNBC |
| Drug Companies Abbott Laboratories, B. Braun Medical Ltd. and Roxane Laboratories, Inc., Paying $421 Million to Settle Govenrment Case | December 07, 2010 | BioSpace |
| Bristol-Myers, Abbott plan to advance cancer drug | December 07, 2010 | Health News - CNBC |
| Report: Abbott ($ABT) hired doc banned by hospital | December 06, 2010 | FiercePharma |
| Sucampo and Abbott One Step Closer to Japanese Approval of Constipation Drug | November 30, 2010 | Inside Industry - Gen |
| Sucampo and Abbott Report New Phase III Data for Constipation Drug in Japanese Patients | November 30, 2010 | Inside Industry - Gen |
| Abbott appointed in UniversalProcon recruitment drive | November 29, 2010 | Pharmaceutical - Moreover |
| Abbott Labs’ India units to merge | November 27, 2010 | Pharmaceutical - Moreover |
| Impax Laboratories sued for patent infringement by Abbott relating to Simcor cholesterolreducing drug | November 26, 2010 | Pharmaceutical - Moreover |
| Denise Abbott is appointed following new business wins | November 26, 2010 | Pharmaceutical - Moreover |
| Abbott India and Solvay India to Merge | November 26, 2010 | Pharmaceutical - Moreover |
| Long-Term Data Shows Abbott's HUMIRA® (Adalimumab) Maintains Remission in Adult Crohn’s Disease Patients for Three Years | November 25, 2010 | Pharma News - PharmiWeb |
| Abbott Labs India units to merge | November 24, 2010 | Pharmaceutical - Moreover |
| US Abbott Labs' Indian units agree to merge | November 24, 2010 | Pharmaceutical - Moreover |
| Deal snapshot: US ABBOTT LABS' INDIAN UNITS AGREE TO MERGE | November 24, 2010 | Pharmaceutical - Moreover |
| Abbott Again Recognized for Leadership in Workplace Diversity and Inclusion | November 23, 2010 | Pharma News - PR Newswire |
| Abbott drug meets goals in kidney disease study | November 22, 2010 | Health News - CNBC |
| Abbott Laboratories Announces Positive Results from Phase 2 Study of Low Dose Atrasentan for Treatment of Diabetic Kidney Disease | November 22, 2010 | BioSpace - Breaking News |
| Reata Pharmaceuticals, Inc. and Abbott Laboratories Announce Positive Phase 2b Study Results for Bardoxolone Methyl | November 22, 2010 | BioSpace - Breaking News |
| Abbott Announces Positive Results from Phase 2 Study of Low Dose Atrasentan for Treatment of Diabetic Kidney Disease | November 22, 2010 | Pharma News - PR Newswire |
| Reata and Abbott Announce Positive Phase 2b Study Results for Bardoxolone Methyl | November 20, 2010 | Pharma News - PR Newswire |
| Abbott Labs - Worst Performing Pharmaceutical | November 18, 2010 | Pharmaceutical - Moreover |
| Abbott Named One of America's Most Generous Companies, Sets Company Records for Employee Giving | November 16, 2010 | Pharma News - PR Newswire |
| Abbott Awards Scholarships to Students Living with Cystic Fibrosis to Help Them Pursue Their Dreams | November 11, 2010 | Medical Pharma - PR Newswire |
| Abbott Laboratories Remains on the Dow Jones & Co. Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance | November 09, 2010 | BioSpace - Breaking News |
| Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance | November 08, 2010 | Biotech News - PR Newswire |
| Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa | November 08, 2010 | Biotech News - PR Newswire |
| Abbott Presents Data Exploring Relationship of Physical Function to Inflammation and Structural Damage in RA | November 08, 2010 | Biotech News - PR Newswire |
| Abbott Laboratories (ABT) Wins Two Scrip Awards Recognizing Excellence in Pharmaceutical and Biotech Industries | November 06, 2010 | Pharmaceutical - Moreover |
| Amgen, Abbott Win BayBio Awards | November 05, 2010 | Xconomy Life Sciences |
| Abbott Wins Two Scrip Awards Recognizing Excellence in Pharmaceutical and Biotech Industries | November 05, 2010 | Medical Pharma - PR Newswire |
| Abbott Laboratories (ABT) Challenges $1. | November 03, 2010 | Biotechnology - Moreover |
| Abbott Laboratories Challenges $1.67 Billion Patent Loss to Johnson & Johnson Over Humira | November 03, 2010 | BioSpace |
| Abbott fights $1.67B Humira verdict in court | November 03, 2010 | FiercePharma |
| Abbott Awarded Brain Research Foundation's First Frederic A. Gibbs Discovery Award | November 02, 2010 | Medical Pharma - PR Newswire |
| Abbott to Present at 2010 Credit Suisse Annual Health Care Conference | November 02, 2010 | Pharma News - PR Newswire |
| Abbott Laboratories and Enanta Pharmaceuticals, Inc. Present Positive Initial Results from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C | November 01, 2010 | BioSpace - Breaking News |
| Abbott and Enanta Present Positive Initial Results from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C | November 01, 2010 | Pharma News - PR Newswire |
| Abbott Promises Aid to Tackle Haiti Cholera Outbreak | October 29, 2010 | Pharmaceutical - Moreover |
| Abbott Again Recognized for Environmental Initiatives in Illinois | October 28, 2010 | Pharma News - PR Newswire |
| Abbott Statement: Abbott Provides Support for Cholera Relief Efforts in Haiti | October 27, 2010 | Pharma News - PR Newswire |
| Myriad joins Abbott Labs' breast cancer study | October 27, 2010 | Health News - CNBC |
| Myriad gains from Abbott testing deal | October 27, 2010 | FierceBiotech |
| Myriad Genetics, Inc. and Abbott Laboratories Enter Into Cooperative Agreement for Phase III Breast Cancer Study | October 27, 2010 | BioSpace |
| FDA Adds Cardiac Warning to Roche's Invirase and Abbott Laboratories's Norvir Combination | October 22, 2010 | BioSpace - Breaking News |
| Abbott Q3 net sales up 11.8% | October 22, 2010 | Pharmaceutical - Moreover |
| FDA Warns On Possible Heart, Diabetes Risk With Prostate Cancer Drugs Including Abbott Laboratories' Lupron, AstraZeneca PLC's Zoladex, Sanofi-Aventis (France)'s Eligard, and Pfizer Inc.'s Synarel | October 21, 2010 | BioSpace |
| Abbott Sales Soar as Earnings Fall | October 21, 2010 | Pharmaceutical - Moreover |
| Abbott net earnings dips by 39.8% in Q3 to $891 million | October 21, 2010 | Pharmaceutical - Moreover |
| FDA Warns On Possible Heart, Diabetes Risk With Prostate Cancer Drugs Including Abbott Laboratories' Lupron, AstraZeneca PLC's Zoladex, Sanofi-Aventis (France)'s Eligard, and Pfizer Inc.'s Synarel
. | October 21, 2010 | BioSpace - Breaking News |
| Abbott Labs 3Q Profit Tumbles on Higher Expenses | October 20, 2010 | Health News - Fox Business |
| Summary Box: Abbott beats earnings estimates | October 20, 2010 | Health News - CNBC |
| Abbott Laboratories (ABT) Profit Falls 40% on Acquisition, Recall Costs | October 20, 2010 | Biotechnology - Moreover |
| On the Call: Abbott on baby formula recall | October 20, 2010 | Health News - CNBC |
| Abbott Laboratories Profit Falls 40% on Acquisition, Recall Costs | October 20, 2010 | BioSpace - Breaking News |
| Financial Report: Abbott 3Q | October 20, 2010 | Contract Pharma |
| Abbott To Report Q3 Results | October 20, 2010 | Pharmaceutical - Moreover |
| Abbott Profit Slightly Tops View, Sales Fall Short | October 20, 2010 | Health News - CNBC |
| Abbott Third-quarter Net Income Falls 40% | October 20, 2010 | Health News - Fox Business |
| Abbott 3Q profit falls on Solvay, Meridia costs | October 20, 2010 | Health News - CNBC |
| Abbott Reports Strong Third Quarter Results; Confirms Double-Digit Ongoing Earnings Outlook for 2010 | October 20, 2010 | Pharma News - PR Newswire |
| Abbott Laboratories Seeks Strategic Partnerships (10/18/10) | October 19, 2010 | Biotechnology - Moreover |
| Abbott Labs - Pharma manufacturing consent decrees | October 19, 2010 | FiercePharma Manufacturing |
| Cheerleaders vs. Graybeards: Abbott Labs Discrimination Case Reveals War in Big Pharma | October 13, 2010 | Pharmaceutical - Moreover |
| Qiagen, Abbott sign contract over HIV, HPV tests | October 12, 2010 | Health News - CNBC |
| QIAGEN and Abbott Enter Into Agreement on Molecular Tests for HIV, HCV and HPV | October 12, 2010 | Biotech News - PR Newswire |
| Abbott Reports Psoriasis Phase III Results of its Investigational IL-12/23 Inhibitor Briakinumab (ABT-874) | October 11, 2010 | Medical Pharma - PR Newswire |
| Abbott Labs (Investor's Business Daily) | October 09, 2010 | Pharmaceutical - Moreover |
| Abbott Labs | October 09, 2010 | Pharmaceutical - Moreover |
| Keller Rohrback L.L.P. Investigates Abbott Laboratories Regarding Weight-Loss Drug Meridia | October 08, 2010 | FDA News - Business Wire |
| Abbott Labs Withdraws Meridia From Market | October 08, 2010 | New York Times- Pharmaceuticals |
| WSJ UPDATE: Abbott Pulls Diet Drug Meridia Off US Shelves | October 08, 2010 | Health News - Fox Business |
| Abbott Laboratories to Stop Selling Meridia in the US | October 08, 2010 | Health News - Fox Business |
| Abbott Laboratories Withdraws Meridia, a Diet Drug, From Market | October 08, 2010 | New York Times- Pharmaceuticals |
| Abbott pulls Meridia in multiple markets | October 08, 2010 | FiercePharma |
| BREAKING NEWS: Abbott pulls Meridia in multiple markets | October 08, 2010 | FiercePharma |
| Abbott Named One of the 'Top Employers' in the Biotech and Pharmaceutical Industry by Science Magazi | October 08, 2010 | Pharmaceutical - Moreover |
| Abbott Yanks Diet-drug From Canadian Market | October 08, 2010 | Health News - Fox Business |
| Abbott Yanks Diet-drug Meridia From US Market | October 08, 2010 | Health News - Fox Business |
| Abbott Halts Meridia Sales In US, Canada, Australia | October 08, 2010 | Health News - Fox Business |
| Abbott Laboratories Pulls Weight Loss Drug Meridia | October 08, 2010 | BioSpace |
| Abbott pulls Meridia off the market in Canada | October 08, 2010 | Health News - CNBC |
| Abbott withdraws diet pill in US, Canada | October 08, 2010 | Health News - CNBC |
| Abbott to Voluntarily Withdraw Meridia® (Sibutramine) in the U.S. | October 08, 2010 | Pharma News - PR Newswire |
| Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia | October 08, 2010 | Pharma News - PR Newswire |
| Abbott Laboratories Pulls Weight Loss Drug Meridia From Australia | October 08, 2010 | BioSpace - Breaking News |
| Abbott Laboratories Named One of the 'Top Employers' in the Biotech and Pharmaceutical Industry by Science Magazine | October 08, 2010 | BioSpace - Breaking News |
| Abbott Named One of the 'Top Employers' in the Biotech and Pharmaceutical Industry by Science Magazine | October 07, 2010 | Biotech News - PR Newswire |
| Sucampo, Abbott File In Japan On Constipation Drug | October 07, 2010 | Health News - Fox Business |
| Reata Pharmaceuticals, Inc. Adding Jobs, Stays in Dallas Because of Abbott Laboratories Deal | October 04, 2010 | BioSpace - Breaking News |
| Recipharm Acquires Abbott Mfg. Site in Spain | October 01, 2010 | Contract Pharma |
| <b>Recipharm AB</b> Acquires Abbott Laboratories Manufacturing Site in Spain | October 01, 2010 | BioSpace - Breaking News |
| Recipharm AB acquires Abbott Manufacturing Site in Spain | October 01, 2010 | Pharma News - PharmiWeb |
| Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution | September 29, 2010 | Pharma News - PR Newswire |
| Abbott Hosts Conference Call for Third-Quarter Earnings | September 29, 2010 | Pharma News - PR Newswire |
| Johnson & Johnson, Pfizer, Abbott Labs, GlaxoSmithKline, TSA and More Address Top Challenges in the Transportation & Transfer of Biologics, Addressing Logistics & Distribution, Quality Assurance and Regulatory & Compliance | September 28, 2010 | Pharma News - Business Wire |
| Reata Strikes Lucrative Deal with Abbott Rakes in the Cash | September 24, 2010 | Burrill Report |
| Abbott's XIENCE V® Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial | September 23, 2010 | Clinical Trials - PR Newswire |
| Reata-Abbott deal may be worth $800M-plus | September 23, 2010 | Health News - BizJournals.com |
| Abbott to Pay Reata $450M for Pivotal Trial-Stage Chronic Kidney Disease Compound | September 23, 2010 | Inside Industry - Gen |
| Abbott's XIENCE V® Shows Outstanding Two-Year Clinical Results Versus TAXUS® in Key Safety and Efficacy Measures in SPIRIT IV Trial | September 23, 2010 | Pharma News - PR Newswire |
| Abbott To Pay At Least $450 Million For Overseas Rights To Kidney Drug | September 23, 2010 | Health News - Fox Business |
| Abbott Laboratories Recalls Beetle-Tainted Similac Baby Formula | September 23, 2010 | BioSpace - Breaking News |
| Abbott Pays Reata $450M for Pivotal Trials-Stage Chronic Kidney Disease Drug | September 23, 2010 | Inside Industry - Gen |
| Abbott Laboratories and Reata Pharmaceuticals, Inc. Announce Agreement Worth at Least $450 Million to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. | September 23, 2010 | BioSpace - Breaking News |
| Reata scores $450M in quick cash from Abbott pact | September 23, 2010 | FierceBiotech |
| Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. | September 23, 2010 | Pharma News - PR Newswire |
| Abbott Laboratories to Cut 3,000 Jobs Following Solvay Pharmaceuticals, Inc. Deal | September 22, 2010 | BioSpace - Breaking News |
| Abbott Recalling 5 Million Containers Of Similac Baby Powder | September 22, 2010 | Health News - Fox Business |
| Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results | September 22, 2010 | Clinical Trials - PR Newswire |
| Abbott recalls infant formula on bug contamination | September 22, 2010 | Health News - CNBC |
| Abbott Recalls Baby Formula Over Beetle Concern | September 22, 2010 | Health News - Fox Business |
| Savient Pharmaceuticals, Inc.'s Gout Drug Nod May Trigger Bid War; Abbott Laboratories, Pfizer Inc., Amgen Seen as Likely Suitors | September 22, 2010 | BioSpace - Breaking News |
| Abbott Labs plans cost-cutting, 3,000 job losses as a result of Solvay integration | September 22, 2010 | Pharmaceutical - Moreover |
| Abbott to axe 500 jobs in Weesp, Netherlands | September 22, 2010 | Pharmaceutical - Moreover |
| Layoffs return with Abbott's 3,000 job cuts | September 22, 2010 | FiercePharma |
| Local nutrition unit safe from Abbott cuts | September 22, 2010 | Pharmaceutical - Moreover |
| Summary Box: Abbott to cut 3,000 Solvay jobs | September 21, 2010 | Health News - CNBC |
| Abbott Plans to Cut 3,000 Jobs | September 21, 2010 | New York Times- Pharmaceuticals |
| Abbott plans 3,000 job cuts tied to Solvay deal | September 21, 2010 | Health News - CNBC |
| Abbott expects more than $1B in Solvay charges | September 21, 2010 | Health News - CNBC |
| Abbott Labs slashing R&D as it cuts 3,000 workers | September 21, 2010 | FierceBiotech |
| Abbott To Cut 3,000 Jobs In Integration Of Solvay Unit | September 21, 2010 | Health News - Fox Business |
| The Deal Names Abbott Top Dealmaker for Third Consecutive Year Awards Recognize Industry-Leading Companies That Demonstrate Effective Strategic Use of Mergers and Acquisitions Over Past Three Years | September 20, 2010 | Pharmaceutical - Moreover |
| Abbott Introduces Sports Nutrition Performance Beverage - EAS Peak™ With New P3™ Technology | September 20, 2010 | Medical Pharma - PR Newswire |
| The Deal Names Abbott Top Dealmaker for Third Consecutive Year | September 20, 2010 | Biotech News - PR Newswire |
| Celera Signs Agreement with Abbott for Distribution of CE-marked KIF6 Test to Identify Patients at Risk of Coronary Heart Disease | September 20, 2010 | Pharma News - Business Wire |
| Pronova BioPharma ASA (NO) - Pronova Biopharma and Abbott amend multinational partnering agreement for Omacor® in 69 countries | September 18, 2010 | Pharmaceutical - Moreover |
| Abbott Declares 347th Consecutive Quarterly Dividend | September 16, 2010 | Pharma News - PR Newswire |
| Abbott Launches New Ensure® Shakes with Focus on Helping Baby Boomers Regain Muscle and Strength | September 16, 2010 | Medical Pharma - PR Newswire |
| Abbott to Present Data on Market-Leading XIENCE V® and Promising Vascular Pipeline at TCT 2010 | September 16, 2010 | Pharma News - PR Newswire |
| Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine | September 15, 2010 | Pharma News - PR Newswire |
| Pronova Biopharma and Abbott amend multinational partnering agreement for Omacor® in 69 countries | September 15, 2010 | Pharmaceutical - Moreover |
| Abbott Honored for Workplace Leadership for the Tenth Consecutive Year by Working Mother Magazine | September 14, 2010 | Pharma News - PR Newswire |
| U.S. to Ask Panel Whether to Ban Abbott Laboratories Diet Drug | September 14, 2010 | BioSpace |
| FDA Mulls Removing Abbott Laboratories Weight-Loss Drug Meridia from US Market | September 13, 2010 | BioSpace |
| Abbott Acquires Second-Largest Pharma in India | September 12, 2010 | Pharmaceutical - Moreover |
| Abbott Hits Teva With Another Suit Over Generic Simcor | September 10, 2010 | Pharmaceutical - Moreover |
| Abbott Completes Acquisition of Piramal's Healthcare Solutions Business | September 10, 2010 | Pharmaceutical - Moreover |
| Abbott Completes Acquisition of Piramal’s Branded Generics Business for $3.8 Billion | September 10, 2010 | Pharmaceutical - Moreover |
| FDA: Abbott Recalls Some HIV Blood Screening Tests | September 09, 2010 | Health News - Fox Business |
| Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance | September 09, 2010 | Pharma News - PR Newswire |
| Abbott completes Piramal Health unit buy | September 09, 2010 | Pharmaceutical - Moreover |
| Abbott buys India generic drugmaker for $2.2B | September 09, 2010 | Pharmaceutical - Moreover |
| Abbott buys Piramal's Healthcare Solutions | September 08, 2010 | Pharmaceutical - Moreover |
| Abbott acquires Healthcare Solutions business from Piramal Healthcare | September 08, 2010 | Pharmaceutical - Moreover |
| Abbott Completes Acquisition of Piramal’s Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India | September 08, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories completes Piramel unit buyout | September 08, 2010 | Health News - CNBC |
| Abbott Completes Acquisition of Piramal's Healthcare Solutions Business, Becomes Leading... | September 08, 2010 | Pharmaceutical - Moreover |
| Abbott Completes Piramal's Healthcare Solutions Business Buy | September 08, 2010 | Health News - Fox Business |
| Abbott Completes Acquisition of Piramals Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India | September 08, 2010 | Pharmaceutical - Moreover |
| Abbott Completes Acquisition of Piramal's Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India / Deal propels Abbott to top position in India with pharmaceutical sales expected to exceed $2.5 billion by 2020 | September 08, 2010 | Pharmaceutical - Moreover |
| Abbott Buys Piramal's Healthcare Solutions Business - Quick Facts | September 08, 2010 | Pharmaceutical - Moreover |
| Abbott completes acquisition of Piramal's Healthcare Solutions | September 08, 2010 | Pharmaceutical - Moreover |
| Abbott Completes Acquisition of Piramal's Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India | September 08, 2010 | Pharma News - PR Newswire |
| Research and Markets: Abbott India Limited - a Detailed Product Pipeline Report on the Company | September 06, 2010 | Pharma News - Business Wire |
| Abbott Cancels Potential Sale of Flu-Vaccine Business | September 04, 2010 | Pharmaceutical - Moreover |
| Abbott abandons plans to sell vaccines business | September 03, 2010 | Health News - CNBC |
| Abbott Laboratories Calls Off Sale Of Flu Vaccine Business In Europe | September 03, 2010 | BioSpace |
| Low bids spur Abbott to cancel vax-unit sale | September 03, 2010 | FiercePharma |
| Abbott Laboratories's Diet Drug Meridia Study Shows Drug Raises Heart Attack, Stroke Risk; Renews Calls For U.S. Ban | September 02, 2010 | BioSpace |
| Abbott Laboratories's Diet Drug Study Showing Drug Raises Heart Attack, Stroke Risk Renews Calls For U.S. Ban | September 02, 2010 | BioSpace |
| Abbott Laboratories Diet Drug Meridia Raises Heart Attack, Stroke Risk | September 02, 2010 | BioSpace |
| NEJM fuels calls to withdraw Abbott's Meridia | September 02, 2010 | FiercePharma |
| Abbott's diet drug study renews calls for U.S. ban | September 01, 2010 | Health News - CNBC |
| FDA Gives Abbott a Thumbs-Up for Automated HBV Monitoring Test | September 01, 2010 | Inside Industry - Gen |
| Abbott says FDA approves hepatitis B test | September 01, 2010 | Health News - CNBC |
| Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment | September 01, 2010 | Pharma News - PR Newswire |
| Equity Research on GlaxoSmithKline and Abbott Laboratories - The Emerging Markets Opportunities | September 01, 2010 | Marketwire - Pharma and Biotech |
| Abbott Recalls Lens Solutions In Parts Of Europe, Middle East | August 30, 2010 | Health News - Fox Business |
| Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference | August 30, 2010 | Pharma News - PR Newswire |
| Abbott bows out of Flutiform pact | August 20, 2010 | FierceBiotech |
| Skyepharma PLC Says Abbott Laboratories Quits Flutiform Partnership | August 20, 2010 | BioSpace |
| Abbott denies costing holes | August 19, 2010 | Pharmaceutical - Moreover |
| Abbott Government to hurt pharmaceuticals manufacturing: Carr | August 19, 2010 | Pharmaceutical - Moreover |
| Mr Abbott slugs every Australian with higher cost for prescription drugs | August 18, 2010 | Pharmaceutical - Moreover |
| Abbott warning cites lack of worker qualifications | August 17, 2010 | FiercePharma Manufacturing |
| Abbott spent $600,000 on lobbying in 1Q | August 13, 2010 | Health News - CNBC |
| Abbott Laboratories Launches New Psoriasisanswers.com Web site | August 12, 2010 | BioSpace - Breaking News |
| Abbott Launches New Psoriasisanswers.com Web site | August 12, 2010 | Medical Pharma - PR Newswire |
| Abbott CEO says diversification delivers | August 10, 2010 | FiercePharma |
| Abbott Labs - Best Performing Pharmaceutical | August 06, 2010 | Pharmaceutical - Moreover |
| FDA Panel to Review Abbott Laboratories's Meridia on Sept. 15, 2010 | August 06, 2010 | BioSpace - Breaking News |
| Abbott Buys Piramal,Making It India’s Biggest Drug Maker | August 05, 2010 | Pharmaceutical - Moreover |
| Pfizer, Sanofi-Aventis, Novartis, GlaxoSmithKline, Abbott Laboratories and Merck to Speak at the 9th Polymorphism & Crystallization Scientific Forum | July 30, 2010 | Pharma News - Business Wire |
| USIBC Salutes Abbott Laboratories for 100 Years of Improving Healthcare in India | July 30, 2010 | Pharma News - Business Wire |
| Abbott Laboratories's SIMCOR(R) (Niacin Extended-Release/Simvastatin ) Receives FDA Approval for New Dosage Strengths | July 29, 2010 | BioSpace |
| Abbott Laboratories's SIMCOR(R) ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths | July 29, 2010 | BioSpace |
| Abbott's SIMCOR ® ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths | July 28, 2010 | Pharma News - PR Newswire |
| Abbott Fund-Sponsored Laboratory Training Initiative Helps Stem Critical Shortage of Medical Professionals in California | July 28, 2010 | Medical Pharma - PR Newswire |
| Abbott to Feature Novel Tests and New Upgrades to Testing Platforms at American Association for Clinical Chemistry Lab Expo | July 26, 2010 | Pharma News - PR Newswire |
| Abbott Reports Strong Second Quarter Results | July 25, 2010 | Pharmaceutical - Moreover |
| Humira drug and Solvay purchase boost Abbott sales | July 23, 2010 | Pharmaceutical - Moreover |
| Abbott posts slight Q2 gains, bolstered by 9% increase in stent sales | July 22, 2010 | Pharmaceutical - Moreover |
| Abbott boosted by Solvay integration | July 22, 2010 | Pharmaceutical - Moreover |
| Abbott to Present at Wedbush Securities Life Sciences Best Ideas MAC Conference | July 22, 2010 | Medical Pharma - PR Newswire |
| Abbott Labs 2Q Profits Rise 14% | July 21, 2010 | Pharmaceutical - Moreover |
| On The Call: Abbott CFO discusses higher costs | July 21, 2010 | Health News - CNBC |
| Pharmaceutical, Biotech and Guidance Agencies including GlaxoSmithKline, Noven Pharmaceuticals Inc., Roche Carolina, Pfizer, Eli Lilly, Abbott and More Will Convene to Discuss the Latest in PAT & QbD Initiatives | July 21, 2010 | Pharma News - Business Wire |
| Abbott 2Q earnings flat as sales grow 18% | July 21, 2010 | Pharmaceutical - Moreover |
| Abbott EPS growth tops guidance | July 21, 2010 | Pharmaceutical - Moreover |
| Summary Box: Abbott 2Q profit edges past estimates | July 21, 2010 | Health News - CNBC |
| 2nd UPDATE:Abbott 2Q Net Flat,Acquisition Costs Offset Sales Gains | July 21, 2010 | Health News - Fox Business |
| Abbott Laboratories Profit Exceeds Forecast; All Units Shine | July 21, 2010 | BioSpace |
| Abbott 2Q profit unchanged as costs, sales rise | July 21, 2010 | Health News - CNBC |
| Abbott Q2 Net Income Flat, Sales Rise 18% | July 21, 2010 | Health News - Fox Business |
| Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Ongoing Earnings Growth Outlook for 2010 | July 21, 2010 | Pharma News - PR Newswire |
| FDA Sends Warning Letter To Abbott Diabetes Unit | July 20, 2010 | Health News - Fox Business |
| Abbott Laboratories's PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint | July 19, 2010 | BioSpace |
| Abbott Laboratories Gets Priority Review For Prolia | July 19, 2010 | BioSpace |
| Abbott's PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint | July 19, 2010 | Clinical Trials - PR Newswire |
| Memphis eye bank gets $500,000 from Abbott Medical Optics | July 14, 2010 | Health News - BizJournals.com |
| Merck Joins with the Heinz Family Philanthropies, Welvista and Abbott to Announce Solution to Help Patients on State ADAP Waiting Lists for No-Cost HIV Medications | July 14, 2010 | Pharma News - PR Newswire |
| Datamonitor Report: Abbott Laboratories's Flu Vaccine Business May Represent A Good Deal For Acquisitive Drug Makers | July 12, 2010 | BioSpace |
| Abbott Hosts Conference Call for Second-Quarter Earnings | July 07, 2010 | Pharma News - PR Newswire |
| Abbott executive Bohuon succeeds Garnier as new Pierre Fabre CEO | July 05, 2010 | Pharmaceutical - Moreover |
| Abbott's pharmaceutical head to retire | July 05, 2010 | Pharmaceutical - Moreover |
| UPDATE: Head Of Abbott Pharma Unit To Take Over Pierre Fabre | July 01, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories says pharma chief to retire | July 01, 2010 | Health News - CNBC |
| UPDATE 1-Abbott says pharmaceutical division head resigns | July 01, 2010 | Pharmaceutical - Moreover |
| BRIEF-Abbott Laboratories names Gonzalez as interim EVP, Pharmaceutical products | July 01, 2010 | Pharmaceutical - Moreover |
| Report: Abbott looking to sell Solvay's flu vax unit | June 30, 2010 | FierceVaccines |
| Abbott Rated One of the 'Best in Class' Companies for Responsible Citizenship (6/25/10) | June 30, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories looking to sell vaccines business acquired from Solvay Pharmaceuticals | June 29, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories (ABT) Puts Former Solvay SA Flu-Vaccine Business Up for Sale; Could be Worth $6 | June 29, 2010 | Biotechnology - Moreover |
| Piramal gets shareholders' nod for Abbott deal | June 29, 2010 | Pharmaceutical - Moreover |
| Abbott consider selling vaccines business | June 29, 2010 | Pharmaceutical - Moreover |
| Abbott considers selling vaccines business | June 29, 2010 | Health News - CNBC |
| Abbott Laboratories Puts Former Solvay SA Flu-Vaccine Business Up for Sale; Could be Worth $619 Million | June 29, 2010 | BioSpace |
| Abbott targets sale of Solvay flu-vax unit | June 29, 2010 | FiercePharma |
| Abbott Laboratories Looks to Sell its Flu Vaccine Unit; Deal Could Fetch $614 Million | June 29, 2010 | BioSpace |
| Abbott Labs Auctioning Flu Vaccine Business | June 28, 2010 | Health News - Fox Business |
| FDA OKs Abbott Labs test for gonorrhea, chlamydia | June 28, 2010 | Health News - CNBC |
| Abbott Receives FDA Clearance for Molecular Diagnostic Test for Detection of Chlamydia and Gonorrhea Infections | June 28, 2010 | Pharma News - PR Newswire |
| Kowa Company, Ltd. Grants Abbott Exclusive Rights to Market Pitavastatin Calcium, a Lipid-lowering Drug, in Australia and New Zealand | June 28, 2010 | Pharmaceutical - Moreover |
| Minneapolis Heart Institute at Abbott Northwestern Hospital Presents Therapeutic Hypothermia Conference | June 26, 2010 | Pharma News - PharmiWeb |
| FDA OKs Abbott's new diabetes testing strips | June 24, 2010 | Health News - CNBC |
| Abbott Receives FDA Clearance for New, Easier-to-Use FreeStyle(R) Test Strips | June 24, 2010 | Pharma News - PR Newswire |
| Piramal Healthcare Limited to Share Abbott Laboratories Deal Booty with Employees | June 23, 2010 | BioSpace |
| Abbott prepares to acquire Piramal's Healthcare Solutions business and capture top pharma spot in India | June 22, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories, Neurocrine Biosciences, Inc. in Pact for Endometriosis Drug, Elagolix; to Get up to $575 Million | June 16, 2010 | BioSpace |
| Abbott In $575 Million Deal For Endometriosis Drug | June 16, 2010 | Health News - Fox Business |
| Neurocrine Biosciences Announces Conference Call and Webcast on Worldwide Agreement With Abbott on Elagolix | June 16, 2010 | Biotech News - PR Newswire |
| Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis | June 16, 2010 | Biotech News - PR Newswire |
| Abbott Loses Bid To Toss Humira Cancer Suit | June 16, 2010 | Pharmaceutical - Moreover |
| When Is a Sales Rep Not a Sales Rep? When You're at Abbott Laboratories (ABT), Facing More Layoffs Possibly on June | June 15, 2010 | Biotechnology - Moreover |
| Abbott sales reps win overtime-pay lawsuit | June 15, 2010 | FiercePharma |
| When Is a Sales Rep Not a Sales Rep? When You're at Abbott Laboratories, Facing More Layoffs Possibly on June 30th | June 15, 2010 | BioSpace |
| Abbott Labs declares 44 cent quarterly dividend | June 11, 2010 | Health News - CNBC |
| Abbott Declares 346th Consecutive Quarterly Dividend | June 11, 2010 | Medical Pharma - PR Newswire |
| Abbott to Acquire Piramal Healthcare Solutions | June 11, 2010 | Pharmaceutical - Moreover |
| Research and Markets: Abbott Laboratories - a Complete Financial Analysis | June 10, 2010 | Pharma News - Business Wire |
| Drug Research: Research findings from Abbott Laboratories update understanding of drug research | June 09, 2010 | Pharmaceutical - Moreover |
| Abbott gets FDA approval for ovarian cancer test | June 03, 2010 | Health News - CNBC |
| Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting | June 03, 2010 | Medical Pharma - PR Newswire |
| Abbott Receives FDA Clearance for New Ovarian Cancer Test | June 03, 2010 | Pharma News - PR Newswire |
| Abbott to Present at Goldman Sachs 31st Annual Global Healthcare Conference | June 03, 2010 | Medical Pharma - PR Newswire |
| Abbott's Appeal Bid Nixed In Norvir Pricing Suits | June 03, 2010 | Pharmaceutical - Moreover |
| Abbott spent $1.5M on lobbying in first quarter | June 01, 2010 | Health News - CNBC |
| Abbott To Become No. 1 Pharmaceutical Company In India With Acquisition Of... | May 30, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories And The “India Cure” For The Ailing Pharmaceutical Industry | May 27, 2010 | Pharmaceutical - Moreover |
| Abbott Shells Out $3.7 Billion for Piramal | May 27, 2010 | Pharmaceutical - Moreover |
| The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery | May 26, 2010 | Pharma News - PR Newswire |
| Abbott to Acquire Pharma Business From Indian Drugmaker Piramal | May 26, 2010 | Pharmaceutical - Moreover |
| Abbott receives European OK for Trek catheter | May 26, 2010 | Health News - CNBC |
| Abbott Announces European Launch of TREK(TM) Catheter System, Representing an Advancement in Balloon Technology | May 26, 2010 | Pharma News - PR Newswire |
| Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc. | May 26, 2010 | Pharma News - Business Wire |
| Abbott Acquires Piramal's Healthcare Solutions Business | May 26, 2010 | Pharmaceutical - Moreover |
| Biogen Idec, Inc. (Massachusetts) (BIIB), Abbott Laboratories (ABT) Advance Daclizumab for Relapsing-Remitting Multiple Sclerosis; Biogen to Pay $ | May 26, 2010 | Biotechnology - Moreover |
| Abbott to Buy Domestic Formulations Business of India's Piramal Healthcare Solutions | May 26, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories Selling Debt After Buying Several Companies | May 25, 2010 | BioSpace - Breaking News |
| Abbott: Study illustrates safety of MitraClip | May 25, 2010 | Health News - CNBC |
| Biogen Idec, Inc. (Massachusetts), Abbott Laboratories Advance Daclizumab for Relapsing-Remitting Multiple Sclerosis; to Pay $30 Million in Advance | May 25, 2010 | BioSpace - Breaking News |
| Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results | May 25, 2010 | Clinical Trials - PR Newswire |
| Abbott's Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves | May 25, 2010 | Medical Pharma - PR Newswire |
| New Data Reinforces Safety Profile of Abbott's Market-Leading XIENCE V(R) Drug Eluting Stent | May 25, 2010 | Pharma News - PR Newswire |
| Abbott buys Piramal Generic unit to become number one in India | May 24, 2010 | Pharmaceutical - Moreover |
| Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramals Healthcare Solutions Business | May 24, 2010 | Pharmaceutical - Moreover |
| Biogen Idec, Inc. (Massachusetts) and Abbott Laboratories Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapsing-Remitting Multiple Sclerosis | May 24, 2010 | BioSpace - Breaking News |
| Biogen, Abbott advance MS drug trial | May 24, 2010 | Health News - BizJournals.com |
| Citi analyst raises Abbott Labs rating to 'Hold' | May 24, 2010 | Health News - CNBC |
| Abbott Receives FDA Clearance for New, Easier-to-Use FreeStyle Lite® Test Strips | May 24, 2010 | Pharma News - PR Newswire |
| Samenvatting: Biogen Idec en Abbott schrijven eerste patiënt in voor mondiaal fase-3 onderzoek naar behandeling recidief-remitterende multiple sclerose met daclizumab | May 24, 2010 | Pharma News - Business Wire |
| Resumen: Biogen Idec y Abbott anuncian inscripción de primer paciente en estudio mundial de fase III de daclizumab para esclerosis múltiple recurrente-remitente | May 24, 2010 | Pharma News - Business Wire |
| Biogen Idec, Abbott Start Phase III MS Trial | May 24, 2010 | Contract Pharma |
| Abbott Buys Indian Pharma Unit for $3.7 Billion | May 24, 2010 | Pharmaceutical - Moreover |
| Abbott To Become No. 1 Pharmaceutical Company In India With... | May 24, 2010 | Pharmaceutical - Moreover |
| Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapsing-Remitting Multiple Sclerosis | May 24, 2010 | Pharma News - Business Wire |
| Biogen Idec et Abbott annoncent le recrutement du premier patient dansle cadre d'une étude globale de Phase III du Daclizumab dans le traitement de la sclérose en plaques cyclique | May 24, 2010 | Pharma News - Business Wire |
| Biogen Idec und Abbott melden Aufnahme des ersten Patienten in weltweite Phase-III-Studie über Daclizumab zur Behandlung von rezidivierend-remittierender multipler Sklerose | May 24, 2010 | Pharma News - Business Wire |
| Riassunto: Biogen Idec e Abbott annunciano iscrizione del primo paziente allo studio globale di fase III del daclizumab per la sclerosi multipla relapsing-remitting | May 24, 2010 | Pharma News - Business Wire |
| US Abbott buys Indian generic drugs unit for $3.7 billion | May 24, 2010 | Pharmaceutical - Moreover |
| Abbott to Become No. 1 Pharmaceutical Company in India with ... | May 24, 2010 | Pharmaceutical - Moreover |
| Big Pharma's Emerging Market Fever: Abbott Aims for the Top of India's Industry | May 23, 2010 | Pharmaceutical - Moreover |
| Abbott Expands Emerging Market Generic Drug Presence with Piramal Acquisition | May 23, 2010 | Pharmaceutical - Moreover |
| Abbott buys Indian firm's subsidiary for $3.7bn | May 22, 2010 | Pharmaceutical - Moreover |
| Abbott buys Indian pharma | May 22, 2010 | Pharmaceutical - Moreover |
| US Abbott buys Indian pharma unit for $3.7 bln | May 22, 2010 | Pharmaceutical - Moreover |
| Abbott to Become No. 1 Pharmaceutical Company in India | May 22, 2010 | Pharmaceutical - Moreover |
| Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramal's Healthcare Solutions Business (5/21/10) | May 22, 2010 | Pharmaceutical - Moreover |
| Abbott to become No. 1 pharmaceutical company in India with acquisition | May 22, 2010 | Pharmaceutical - Moreover |
| Abbott Labs buying Indian drug maker | May 22, 2010 | Pharmaceutical - Moreover |
| Abbott deal set to bolster emerging markets share | May 22, 2010 | Pharmaceutical - Moreover |
| Abbott buys Piramal's pharma arm for $3.7bn | May 22, 2010 | Pharmaceutical - Moreover |
| Abbott (ABT) Announces $3.72B Acquisition of Piramal Health Solutions Business; To Become No. 1 Pharma Co. in India | May 22, 2010 | Pharmaceutical - Moreover |
| After Piramal acquisition, Abbott becomes leading drug seller | May 22, 2010 | Pharmaceutical - Moreover |
| Abbott Acquires Piramal's Domestic Drug Biz | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott to buy Piramal business for $3.72 bn | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott to Acquire Piramal’s Pharma Business, Expand in Emerging Markets | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott to pay 17K crore for Piramal generics business | May 21, 2010 | Pharmaceutical - Moreover |
| US-based Abbott buys Piramal's pharma arm for $3.7bn | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott Labs Fills Indian Prescription | May 21, 2010 | Pharmaceutical - Moreover |
| PerkinElmer and Abbott to Present on Time-of-Flight Mass Spectrometry for Pathogen Detection Research at ASMS 2010 | May 21, 2010 | Biotech News - Business Wire |
| Abbott Buys Drug Maker In India for $3.7 Billion | May 21, 2010 | New York Times- Pharmaceuticals |
| Borders Group, Dell, Abbott among big movers | May 21, 2010 | Health News - CNBC |
| Abbott Laboratories (ABT) Buys Piramal Healthcare Limited Biz for $3. | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott falls on acquisition deal; Anadys climbs | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott Learns to Say "Low Margin" in Hindi | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramal’s Healthcare Solutions Business | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott Boosts Presence in India with Acquisition of Generics Business for $3.72B | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott purchases healthcare solutions provider | May 21, 2010 | Pharmaceutical - Moreover |
| India On Deck For Abbott Labs | May 21, 2010 | Pharmaceutical - Moreover |
| Moody's considers Abbott downgrade on deal | May 21, 2010 | Health News - CNBC |
| Abbott to acquire Piramal's domestic drug biz for USD 3.72bn | May 21, 2010 | Pharmaceutical - Moreover |
| Moody's May Downgrade Abbott Lab On Piramal Deal | May 21, 2010 | Health News - Fox Business |
| Abbott To Buy Domestic Formulations Business Of India's Piramal Healthcare For $3.72 Bln - Update | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories Buys Piramal Healthcare Limited Biz for $3.72B | May 21, 2010 | BioSpace |
| Abbott Buys Indian Drug Maker for $3.7 Billion | May 21, 2010 | New York Times- Pharmaceuticals |
| Abbott captures Piramal in $3.7B deal | May 21, 2010 | FiercePharma |
| S&P affirms Abbott Laboratories ratings | May 21, 2010 | Health News - CNBC |
| Abbott Falls On Acquisition Deal; Indices Split | May 21, 2010 | Health News - Fox Business |
| Abbott recognised as one of the UK's Best Workplaces by the Great Place to Work® Institute | May 21, 2010 | Pharma News - PharmiWeb |
| Abbott captures Piramal with $3.7B deal | May 21, 2010 | FiercePharma |
| Abbott to acquire Piramal's domestic drug biz for $ 3.72b | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott to buy generics unit of India's Piramal for $3.72 bln | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott in $3.7bn deal for India drugs unit | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott buys Piramal`s health sol biz | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott buys India drugs unit for $3.7bn | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott to Buy India Piramal's Health Unit for $3.7 Billion | May 21, 2010 | Health News - Fox Business |
| Abbott to buy Piramal's drug business | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott Buys Piramal Unit for $3.72B | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott acquires India's Piramal Health for $3.72 bn | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott buys Piramal Healthcare biz for $3.72 bn | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott buys unit of Piramal Healthcare for $3.7B | May 21, 2010 | Health News - CNBC |
| Abbott To Acquire Piramal Business For $3.7 Bln | May 21, 2010 | Health News - Fox Business |
| Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramal's Healthcare... | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott buys Piramal Healthcare Solutions business | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott To Buy Piramal's Healthcare Solutions Business For Over 2.12 Billion | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott to acquire Piramal's Healthcare Solutions business | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott to acquire Piramal's domestic drug biz for USD 3.72 bn | May 21, 2010 | Pharmaceutical - Moreover |
| Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramal's Healthcare Solutions Business | May 21, 2010 | Pharma News - PR Newswire |
| Abbott to Present New Clinical Data on Current and Future Innovations in Interventional Cardiology at EuroPCR 2010 | May 20, 2010 | Medical Pharma - PR Newswire |
| Abbott Honored as a Great Place to Work Across Europe | May 20, 2010 | Medical Pharma - PR Newswire |
| Abbott Labs gets FDA approval for new blood test | May 19, 2010 | Health News - CNBC |
| Abbott Receives FDA Approval for First Fully Automated Blood Test for 'Kissing Bug' Disease | May 19, 2010 | Medical Pharma - PR Newswire |
| Abbott - Moving Further into Emerging Markets | May 14, 2010 | Pharmaceutical - Moreover |
| Abbott licenses 24 Zydus pharmaceutical products for 15 high-growth emerging markets | May 13, 2010 | Pharmaceutical - Moreover |
| Abbott Presents Do-It-Yourself Home Makeover Tips for Arthritis Awareness Month | May 13, 2010 | Pharma News - PR Newswire |
| Abbott Signs Supply Agreement With Zydus Cadila | May 12, 2010 | Pharmaceutical - Moreover |
| Abbott and Zydus Cadila enter alliance for emerging markets | May 12, 2010 | Pharmaceutical - Moreover |
| Eyeing emerging markets, Abbott nabs Zydus Cadila deal | May 12, 2010 | FiercePharma |
| Abbott collaborates with Zydus Cadila | May 12, 2010 | Pharmaceutical - Moreover |
| Abbott to commercialize Cadila's drugs globally | May 12, 2010 | Pharmaceutical - Moreover |
| CORRECT: Abbott Makes Licensing Deal With Indian Co Zydus Cadila | May 11, 2010 | Pharmaceutical - Moreover |
| Cadila Healthcare in pact with Abbott for branded generics | May 11, 2010 | Pharmaceutical - Moreover |
| Zydus Cadila, Abbott ink licensing and supply deal | May 11, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories (ABT) Confirms | May 11, 2010 | Biotechnology - Moreover |
| Abbott (ABT) Announces Licensing and Supply Agreement with Zydus Cadila of India; Enables Access to 15 Key Emerging Markets | May 11, 2010 | Pharmaceutical - Moreover |
| Abbott Makes Licensing Deal With Indian Company Zydus Cadila | May 11, 2010 | Pharmaceutical - Moreover |
| BRIEF-Abbott to gain rights to at least 24 Zydus products in 15 emerging markets | May 11, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories Accelerates Emerging Markets Pharmaceutical Leadership With Zydus Cadila Collaboration; Separately Creates Stand-Alone Established Products Division | May 11, 2010 | BioSpace - Breaking News |
| Abbott Laboratories Confirms 75 New Jobs for Donegal Town, Ireland | May 11, 2010 | BioSpace |
| Abbott To Market Zydus Cadila Products in Emerging Markets | May 11, 2010 | Contract Pharma |
| Abbott Enters Licensing And Supply Deal With Zydus Cadila Of India; Creates Stand-alone Established Products Division - Quick Facts | May 11, 2010 | Pharmaceutical - Moreover |
| Abbott in new deal to target emerging markets | May 11, 2010 | Health News - CNBC |
| Abbott signs licensing deal with Zydus, forms unit | May 11, 2010 | Health News - CNBC |
| Abbott Accelerates Emerging Markets Pharmaceutical Leadership With Zydus Cadila Collaboration; Separately Creates Stand-Alone Established Products Division | May 11, 2010 | Medical Pharma - PR Newswire |
| Assegai Wins Big Settlement Against ABBOTT's Subsidiary | May 10, 2010 | Pharma News - PharmiWeb |
| Heinz Family Philanthropies, Welvista and Abbott Announce Solution to Help Patients on State ADAP Waiting Lists for No-Cost HIV Medications | May 07, 2010 | Pharma News - PR Newswire |
| Abbott 2009 Global Citizenship Report Highlights Company's Progress in 'Redefining Responsibility' | May 06, 2010 | Pharma News - PR Newswire |
| The New England Journal of Medicine Publication of SPIRIT IV Trial Results Confirm Superior Safety and Efficacy of Abbott's XIENCE V(R) Drug Eluting Stent Compared to TAXUS | May 05, 2010 | Medical Pharma - PR Newswire |
| Abbott Chairman and CEO Miles D. White to Present at Sanford Bernstein Strategic Decisions Conference | May 05, 2010 | Biotech News - PR Newswire |
| Abbott Prism Chagas | May 05, 2010 | FDA Vaccines, Blood and Biologics - What's New |
| Abbott Vascular's Xience V Drug-Eluting Stent Experiences Rapid Adoption During Its Q1 2010 Launch, According To Millennium Research Group | May 05, 2010 | Medical Pharma - PR Newswire |
| Abbott Laboratories Opens Asia-Pacific Nutrition Research & Development Center in Singapore | May 05, 2010 | BioSpace - Breaking News |
| Abbott Opens Asia-Pacific Nutrition Research & Development Center in Singapore | May 05, 2010 | Medical Pharma - PR Newswire |
| US FDA Probes Risks of HIV, Prostate, Other Drugs; Abbott Laboratories' Kaletra, GlaxoSmithKline's Avodart on List | May 04, 2010 | BioSpace - Breaking News |
| US FDA Probes Risks of HIV, Prostate, Other Drugs; Abbott Laboratories's Kaletra, GlaxoSmithKline's Avodart on List | May 04, 2010 | BioSpace |
| Abbott Laboratories Receives FDA Approval for CREON(R) to Include Dosing Information for Patients With Chronic Pancreatitis and Pancreatectomy | May 03, 2010 | BioSpace |
| Abbott Receives FDA Approval for CREON(R) to Include Dosing Information for Patients With Chronic Pancreatitis and Pancreatectomy | May 03, 2010 | Pharma News - PR Newswire |
| Abbott Recognized as One of the Best Places to Work in Industry' by The Scientist magazine | April 29, 2010 | Pharma News - PharmiWeb |
| Abbott Laboratories Receives FDA Approval for Once-Daily Dosing of Kaletra (R) (lopinavir / ritonavir) for Treatment-Experienced Patients | April 28, 2010 | BioSpace - Breaking News |
| Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra (R) (lopinavir / ritonavir) for Treatment-Experienced Patients | April 28, 2010 | Pharma News - PR Newswire |
| Abbott Recognized as One of the 'Best Places to Work in Industry' by The Scientist magazine | April 28, 2010 | Medical Pharma - PR Newswire |
| Abbott Laboratories: PharmaVitae Profile - new market report released | April 26, 2010 | Pharmaceutical - Moreover |
| Abbott Q1 Net Sales Up 14.6% | April 25, 2010 | Pharmaceutical - Moreover |
| Abbott India Limited-Company Report - New Report Published | April 23, 2010 | Biotechnology - Moreover |
| Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010 | April 23, 2010 | Pharma News - PR Newswire |
| Abbott Completes Acquisition of Facet Biotech (4/21/10) | April 23, 2010 | Pharmaceutical - Moreover |
| Abbott acquires Facet Biotech | April 22, 2010 | Pharmaceutical - Moreover |
| Abbott Reports Strong First Quarter Results | April 22, 2010 | Pharmaceutical - Moreover |
| Healthcare reforms drag on Abbott's Q1 profits and full-year targets | April 21, 2010 | Pharmaceutical - Moreover |
| Abbott Lowers Guidance After Beat | April 21, 2010 | Pharmaceutical - Moreover |
| Abbott Completes Its Acquisition Of Facet Biotech Corp. - Quick Facts | April 21, 2010 | Pharmaceutical - Moreover |
| On the Call: Abbott acquisitions in 2010 | April 21, 2010 | Health News - CNBC |
| Abbott Completes Acquisition of Facet Biotech | April 21, 2010 | Biotech News - PR Newswire |
| Summary Box: Abbott maps post-reform trajectory | April 21, 2010 | Health News - CNBC |
| Analysts like Abbott's post-health reform guidance | April 21, 2010 | Health News - CNBC |
| 2nd UPDATE:Abbott 1Q Net Falls 30% On '09 Gain;EPS View Revised | April 21, 2010 | Health News - Fox Business |
| Abbott sales rise 15% as Elan loss shrinks | April 21, 2010 | FiercePharma |
| Abbott Laboratories Beats Forecasts as All Product Lines Shine | April 21, 2010 | BioSpace |
| Abbott 1Q Earnings Fall 31% On 2009 Gain; EPS View Revised | April 21, 2010 | Pharmaceutical - Moreover |
| Abbott reports lower profit, higher revenue | April 21, 2010 | Pharmaceutical - Moreover |
| UPDATE: Abbott 1Q Earnings Fall 30% On 2009 Gain; EPS View Revised | April 21, 2010 | Health News - Fox Business |
| Abbott Labs 1Q profit falls 30 pct, revenue climbs | April 21, 2010 | Health News - CNBC |
| Abbott Reports Lower First-quarter Profit | April 21, 2010 | Health News - Fox Business |
| Abbott Reports Strong First Quarter Results; Forecasts Double-Digit Ongoing Earnings Growth in 2010 | April 21, 2010 | Medical Pharma - PR Newswire |
| Financial Reports: Abbott Laboratories | April 21, 2010 | Contract Pharma |
| Abbott Laboratories Successfully Completes Tender Offer for Shares of Facet Biotech | April 20, 2010 | BioSpace - Breaking News |
| Abbott Successfully Completes Tender Offer for Shares of Facet Biotech | April 20, 2010 | Biotech News - PR Newswire |
| Earnings Preview: Abbott Laboratories | April 19, 2010 | Health News - CNBC |
| Abbott Begins Biopreparedness Evaluation Program With State Public Health Labs | April 15, 2010 | Pharma News - PR Newswire |
| Abbott ordered to turn over e-mails for govt probe | April 13, 2010 | Health News - CNBC |
| Abbott Laboratories Must Produce CEO's Emails For Probe | April 13, 2010 | BioSpace |
| Abbott Laboratories Must Produce CEO???s Emails For Probe | April 13, 2010 | BioSpace |
| Prosecutors win access to Abbott chief's email | April 13, 2010 | FiercePharma |
| Abbott's Facet Biotech Bid Clears Antitrust Hurdle | April 09, 2010 | Biotechnology - Moreover |
| Abbott's buyout of Facet passes antitrust period | April 08, 2010 | Health News - CNBC |
| Abbott Laboratories Acquisition of Facet Biotech Clears U.S. Antitrust Review | April 08, 2010 | BioSpace - Breaking News |
| Abbott Acquisition of Facet Biotech Clears U.S. Antitrust Review | April 08, 2010 | Medical Pharma - PR Newswire |
| AIDS Foundation of Chicago and Abbott Mark 25-Year Milestones in the Fight Against AIDS | April 05, 2010 | Pharma News - Business Wire |
| Wockhardt, Abbott Laboratories Call Off Nutrition Business Deal | April 02, 2010 | BioSpace |
| Wockhardt-Abbott deal aborted | April 02, 2010 | Pharmaceutical - Moreover |
| Abbott's White makes list of world's top CEOs | March 31, 2010 | FiercePharma |
| Abbott Submits Test to Aid in Identifying Patients at Risk of Developing Kidney Injury | March 31, 2010 | Medical Pharma - PR Newswire |
| Abbott Hosts Conference Call for First-Quarter Earnings | March 31, 2010 | Medical Pharma - PR Newswire |
| AstraZeneca PLC, Abbott Laboratories Combo Heart Drug Snagged at FDA | March 30, 2010 | BioSpace |
| AstraZeneca, Abbott Get FDA Letter For Certriad | March 30, 2010 | Health News - Fox Business |
| Abbott's White Is The (Only) One | March 29, 2010 | Health News - CNBC |
| Abbott Labs posts higher profit | March 29, 2010 | Pharmaceutical - Moreover |
| Abbott Labs posts higher profit - Zibb.com | March 29, 2010 | Pharmaceutical - Moreover |
| Abbott completes acquisition of Starlims | March 26, 2010 | Pharmaceutical - Moreover |
| Pfizer, Novartis, Eli Lilly, Myriad Pharmaceuticals, Abbott Laboratories, Purdue Pharmaceutical Discuss Legislative Changes & Supply Chain Strategy | March 25, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories Commences Tender Offer for All Outstanding Shares of Facet Biotech | March 23, 2010 | BioSpace - Breaking News |
| Abbott subsidiary starts tender offer for Facet | March 23, 2010 | Health News - CNBC |
| Abbott Laboratories Completes Acquisition of Starlims Technologies | March 23, 2010 | BioSpace - Breaking News |
| Abbott Commences Tender Offer for All Outstanding Shares of Facet Biotech Corporation | March 23, 2010 | Medical Pharma - PR Newswire |
| Greg Abbott: Texas challenging health care bill | March 22, 2010 | Health News - BizJournals.com |
| The Abbott Fund, Boston University School of Medicine and Leading Health Institutions in Vietnam Inaugurate the Abbott Fund Institute of Nutrition Science at Bach Mai Hospital | March 19, 2010 | Pharma News - PR Newswire |
| Abbott Labs: Dividend Stock Analysis | March 19, 2010 | Pharmaceutical - Moreover |
| Abbott CEO pay drops 7% to $26.2M | March 16, 2010 | FiercePharma |
| Abbott CEO pay drops 7% to $26.2 mil | March 16, 2010 | FiercePharma |
| Abbott Labs CEO gets 3% raise, $3.9 million bonus | March 15, 2010 | Pharmaceutical - Moreover |
| Abbott CEO's pay falls on reduced stock options | March 15, 2010 | Health News - CNBC |
| Abbott Laboratories’ ABSORB Trials Positive; Trilipix Patent Challenged | March 15, 2010 | Health News - Fox Business |
| Impax challenges patent on Abbott's Trilipix | March 15, 2010 | Health News - CNBC |
| Impax challenges patent on Abbott cholesterol drug | March 15, 2010 | Health News - BizJournals.com |
| Ahead of the Bell: Abbott heart clip shows promise | March 15, 2010 | Health News - CNBC |
| Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology | March 15, 2010 | Pharma News - PR Newswire |
| UPDATE: Abbott Heart Valve-Repair Tool Meets Goals In Study | March 14, 2010 | Health News - Fox Business |
| Abbott Heart Valve-Repair Tool Meets Goals In Key Study | March 14, 2010 | Health News - Fox Business |
| Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use | March 14, 2010 | Biotech News - PR Newswire |
| Citi Downgrades Abbott Labs on Profit Worries | March 12, 2010 | Health News - Fox Business |
| Abbott shares dip, analyst sees profit concerns | March 12, 2010 | Health News - CNBC |
| Abbott Leads Drugs Stocks Lower | March 12, 2010 | Health News - Fox Business |
| Abbott Labs To Buy Facet Biotech For $450M | March 12, 2010 | Pharmaceutical - Moreover |
| Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer | March 11, 2010 | Pharma News - PR Newswire |
| Abbott gets FDA approval for implantable lens | March 10, 2010 | Health News - CNBC |
| Abbott in $450 Million Deal to Buy Facet | March 10, 2010 | Health News - Fox Business |
| Abbott Experiments with a $450 Million Deal for Facet | March 10, 2010 | Pharmaceutical - Moreover |
| Abbott Labs spent nearly $2 million on lobbying | March 10, 2010 | Health News - CNBC |
| Abbott Laboratories to Buy Facet Biotech for $722 Million | March 10, 2010 | BioSpace |
| US Abbott to buy Facet Biotech for USD450m | March 10, 2010 | Biotechnology - Moreover |
| Abbott Wins OK For Cataract Lens Implant | March 10, 2010 | Health News - Fox Business |
| Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens | March 10, 2010 | Pharma News - PR Newswire |
| Abbott Acquires Facet | March 10, 2010 | Contract Pharma |
| Abbott To Acquire Facet Biotech | March 10, 2010 | Pharmaceutical - Moreover |
| Abbott to Acquire Facet Biotech for $450 Million | March 10, 2010 | Biotechnology - Moreover |
| UPDATE 3-Abbott to buy Facet for $27/shr, topping Biogen bid | March 10, 2010 | Pharmaceutical - Moreover |
| Abbott buys Facet Biotech for $450M | March 10, 2010 | FierceBiotech |
| Facet Biotech Stock Soars on Abbott Bid | March 10, 2010 | Pharmaceutical - Moreover |
| UPDATE 2-Abbott to buy Facet for $27/shr, topping Biogen bid | March 10, 2010 | Pharmaceutical - Moreover |
| Abbott buying Facet Biotech for $450 million cash | March 10, 2010 | Biotechnology - Moreover |
| Abbott to pay $450 million for Facet Biotech | March 10, 2010 | Biotechnology - Moreover |
| BREAKING NEWS: Abbott buys Facet Biotech for $450M | March 10, 2010 | FierceBiotech |
| Abbott Laboratories to Buy Facet Biotech for $722 Million | March 10, 2010 | BioSpace - Breaking News |
| Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet | March 09, 2010 | Pharmaceutical - Moreover |
| Abbott Agrees to Buy Facet Biotech for $450 Million (Update1) | March 09, 2010 | Pharmaceutical - Moreover |
| Abbott to Buy Facet Biotech for 67% Premium | March 09, 2010 | Pharmaceutical - Moreover |
| Abbott Labs to buy Facet Biotech for $722M | March 09, 2010 | Health News - BizJournals.com |
| Abbott paying $450 million for Facet Biotech | March 09, 2010 | Health News - CNBC |
| Abbott Labs To Buy Facet Biotech For $722 Million | March 09, 2010 | Health News - Fox Business |
| Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech | March 09, 2010 | Biotech News - PR Newswire |
| Abbott to Use BG Medicine’s Heart-Failure Biomarker in Point-of-Care Test | March 09, 2010 | GEN News Highlights |
| BG Medicine and Abbott to Develop Galectin-3 Test for the i-STAT® System | March 08, 2010 | Biotech News - Business Wire |
| Abbott executives to chair medical device lobby | March 04, 2010 | Health News - CNBC |
| Abbott Laboratories to Collaborate With GlaxoSmithKline on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy | March 04, 2010 | BioSpace - Breaking News |
| Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy | March 03, 2010 | Biotech News - PR Newswire |
| Abbott Laboratories and Enanta Pharmaceuticals, Inc. Announce Advancement of Hepatitis C Collaboration | March 02, 2010 | BioSpace - Breaking News |
| Abbott and Enanta Announce Advancement of Hepatitis C Collaboration | March 02, 2010 | Clinical Trials - PR Newswire |
| IQPC’s 6th Forum on Laboratory Informatics to Feature Pfizer Biotherapeutics & Bioinnovations Centre, Abbott Laboratories and Johnson & Johnson | March 01, 2010 | Pharma News - Business Wire |
| Form 4 WEST PHARMACEUTICAL SERV For: Feb 24 Filed by: ABBOTT JOSEPH E | March 01, 2010 | Pharmaceutical - Moreover |
| FDA Warns of Heart Problem with Abbott Laboratories , s HIV Drug Combo | February 24, 2010 | BioSpace - Breaking News |
| Abbott to Present at Cowen and Company Annual Health Care Conference | February 24, 2010 | Pharma News - PR Newswire |
| FDA Warns of Heart Problem with Abbott Laboratories, s HIV Drug Combo | February 24, 2010 | BioSpace |
| Abbott completes acquisition of Solvay Pharmaceuticals, eases EU antitrust concerns | February 22, 2010 | Pharmaceutical - Moreover |
| Abbott acquires Solvay Pharmaceuticals | February 22, 2010 | Pharmaceutical - Moreover |
| Company News: Abbott and Solvay Pharmaceuticals | February 22, 2010 | Pharmaceutical - Moreover |
| Abbott Labs Hikes Quarterly Dividend By 10% | February 19, 2010 | Health News - Fox Business |
| Abbott completes Solvay Pharma buy | February 19, 2010 | Pharmaceutical - Moreover |
| Abbott completes Solvay buy | February 17, 2010 | Pharmaceutical - Moreover |
| Abbott eyes 20% in India biz of Solvay | February 17, 2010 | Pharmaceutical - Moreover |
| Abbott Offers To Buy 20% More Of Solvay Pharma India | February 17, 2010 | Pharmaceutical - Moreover |
| Abbott Sues Sun Pharma Again Over Generic Niaspan | February 17, 2010 | Pharmaceutical - Moreover |
| Abbott Completes Acquisition of Solvay | February 16, 2010 | Pharmaceutical - Moreover |
| Abbott closes $6.2 billion Solvay unit buyout | February 16, 2010 | Biotechnology - Moreover |
| Abbott Laboratories Completes Acquisition of Solvay Pharmaceuticals, Inc. | February 16, 2010 | BioSpace - Breaking News |
| Abbott Completes Purchase Of Solvay Pharmaceuticals - Update | February 16, 2010 | Pharmaceutical - Moreover |
| Abbott completes Solvay acquisition | February 16, 2010 | Pharmaceutical - Moreover |
| Abbott acquires Solvay Pharmaceuticals for EUR4.5bn | February 16, 2010 | Pharmaceutical - Moreover |
| Abbott completes Solvay Pharmaceuticals acquisition | February 16, 2010 | Pharmaceutical - Moreover |
| Solvay Becomes Part Of Abbott's Global Pharmaceutical Products Group | February 16, 2010 | Pharmaceutical - Moreover |
| Abbott Completes Acquisition of Solvay Pharmaceuticals - Zibb.com | February 16, 2010 | Pharmaceutical - Moreover |
| Abbott Closes $6.2 Bln Acquisition Of Solvay Pharmaceuticals - Quick Facts | February 16, 2010 | Pharmaceutical - Moreover |
| Abbott acquires Belgium-based Solvay Pharmaceuticals for $6.2 billion | February 16, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories Buy of Solvay Pharmaceuticals, Inc. Drug Unit Wins EU Approval | February 12, 2010 | BioSpace |
| Abbott Laboratories Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets | February 12, 2010 | BioSpace |
| Abbott Divestment Wins EU OK For $6.6B Solvay Deal | February 11, 2010 | Pharmaceutical - Moreover |
| Abbott gets European clearance for Solvay deal | February 11, 2010 | Health News - CNBC |
| Abbott NW gets $5M grant to expand study | February 08, 2010 | Health News - BizJournals.com |
| Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval | February 08, 2010 | Biotech News - PR Newswire |
| Skyepharma PLC Takes Over US Flutiform NDA From Abbott Laboratories | February 05, 2010 | BioSpace |
| Abbott's not finished with dealmaking | February 05, 2010 | FiercePharma |
| Abbott And Novartis Looking Good | February 04, 2010 | Pharmaceutical - Moreover |
| Research and Markets: Partnering Agreements with Abbott 2010 - an in-Depth Insight into One of the World's Leading Biopharma Companies | February 04, 2010 | Pharma News - Business Wire |
| Abbott CEO White still interested in fresh acquisitions | February 04, 2010 | FierceBiotech |
| Abbott Laboratories Enters Into Cancer Pact with France's Pierre Fabre; to Pay $25 Million | February 02, 2010 | BioSpace - Breaking News |
| Abbott Laboratories Enters Into Cancer Pact with France's Pierre Fabre; to Pay $25 Million | February 02, 2010 | BioSpace |
| Abbott pays $25M upfront for Pierre Fabre cancer pact | February 02, 2010 | FierceBiotech |
| Abbott and Pierre Fabre SA Announce Collaboration to Research and Develop Novel Treatments for Cancer | February 01, 2010 | Pharma News - PR Newswire |
| Abbott Reports Double-Digit Sales and Earnings Growth... | January 31, 2010 | Pharmaceutical - Moreover |
| Abbott Reports Double-Digit Sales and Earnings Growth in Q4; Issues Strong Earnings Outlook for 2010 | January 30, 2010 | Pharmaceutical - Moreover |
| Abbott scouts for emerging-markets deals | January 28, 2010 | FiercePharma |
| Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter | January 28, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories tapped Kalido’s model-driven data warehousing infrastructure to revamp—and revive—an overworked BI system. | January 28, 2010 | Pharmaceutical - Moreover |
| Abbott makes earnings gains in FY09, Q4 | January 28, 2010 | Pharmaceutical - Moreover |
| Abbott bullish over 2010 earnings growth | January 28, 2010 | Pharmaceutical - Moreover |
| On the Call: Abbott Laboratories | January 28, 2010 | Pharmaceutical - Moreover |
| Abbott Laboratories Sales Surge, 2010 View Tops Forecasts | January 27, 2010 | BioSpace - Breaking News |
| Abbott Laboratories | January 27, 2010 | Health News - CNBC |
| Abbott Laboratories Sales Surge, 2010 View Tops Forecasts | January 27, 2010 | BioSpace |
| Financial Report: Abbott 4Q | January 27, 2010 | Contract Pharma |
| Abbott Laboratories profit stays flat in 4Q | January 27, 2010 | Health News - CNBC |
| Abbott Laboratories 4th-quarter profit remains flat, but Humira sales continue climb | January 27, 2010 | Health News - CNBC |
| Abbott Labs Posts Fourth-quarter Profit | January 27, 2010 | Health News - Fox Business |
| Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010 | January 27, 2010 | Medical Pharma - PR Newswire |
| Teva Pharmaceuticals is the latest defendant in an Abbott Laboratories patent suit | January 26, 2010 | Pharmaceutical - Moreover |
| (Reuters) - Abbott Laboratories asked a federal court to block Teva Pharmaceutical Industries Ltd. from making a generic version of Abbott's Simcor cholesterol treatment, according to court documents. Abbott said its patents were violated when Israel-base | January 25, 2010 | Pharmaceutical - Moreover |
| European Commission extends deadline for decision on Abbott acqui... | January 25, 2010 | Pharmaceutical - Moreover |
| Earnings Preview: Abbott Laboratories to report 4Q | January 25, 2010 | Health News - CNBC |
| Abbott Submits New HIV Test to FDA for Expedited Review | January 25, 2010 | Medical Pharma - PR Newswire |
| Abbott Offers EU Antitrust Remedies On Solvay Deal | January 22, 2010 | Pharmaceutical - Moreover |
| EU Extends Review Deadline for Solvay Pharmaceuticals, Inc., Abbott Laboratories Deal | January 22, 2010 | BioSpace |
| Abbott Laboratories to Stop European Sales of Diet Drug Sold Under the Names Reductil, Reduxade and Zelium in Europe and Meridia in the United States | January 22, 2010 | BioSpace |
| Abbott to Suspend Marketing of Obesity Medicine Sibutramine in European Union Countries | January 22, 2010 | Pharma News - PharmiWeb |
| EU Extends Review Deadline for Solvay Pharmaceuticals, Inc., Abbott Laboratories Deal | January 22, 2010 | BioSpace |
| Abbott Laboratories to Stop European Sales of Diet Drug Sold Under the Names Reductil, Reduxade and Zelium in Europe and Meridia in the United States | January 22, 2010 | BioSpace |
| Updated Abbott Statement: To Help Respond to Growing Health Crisis, Abbott Increases Aid to $2.5 Million for Haiti Relief and Recovery Efforts | January 19, 2010 | Pharma News - PharmiWeb |
| Updated Abbott Statement: To Help Respond to Growing Health Crisis, Abbott Increases Aid to $2.5 Million for Haiti Relief and Recovery Efforts | January 19, 2010 | Biotech News - PR Newswire |
| <b>Wockhardt</b>, Abbott Laboratories Deal May be Blocked | January 15, 2010 | BioSpace - Breaking News |
| <b>Wockhardt</b>, Abbott Laboratories Deal May be Blocked | January 15, 2010 | BioSpace - Breaking News |
| Abbott Wins CE Mark for Epithelial Ovarian Cancer Diagnostic | January 14, 2010 | GEN News Highlights |
| Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test | January 14, 2010 | Pharma News - PR Newswire |
| Abbott Obtains CE Mark for Epithelial Ovarian Cancer Diagnostic | January 14, 2010 | GEN News Highlights |
| Abbott to Provide $1 Million in Funding, Products to Help Address Health Needs in Haiti | January 14, 2010 | Medical Pharma - PR Newswire |
| Abbott's XIENCE V® Approved in Japan – Second Largest Drug Eluting Stent Market Worldwide | January 11, 2010 | Pharma News - PharmiWeb |
| Abbott Labs Says Heart Stent Approved For Sale in Japan | January 08, 2010 | Health News - Fox Business |
| Abbott Laboratories to Pay States $22.5 Million in TriCor Deal | January 08, 2010 | BioSpace - Breaking News |
| UPDATE:Abbott Gets Approval To Market Popular Stent In Japan | January 08, 2010 | Health News - Fox Business |
| Abbott settles TriCor antitrust claims for $22.5M | January 08, 2010 | FiercePharma |
| Japan Regulators Approve Abbott Xience V Stent | January 08, 2010 | Health News - Fox Business |
| Abbott's XIENCE V(R) Approved in Japan - Second Largest Drug Eluting Stent Market Worldwide | January 08, 2010 | Medical Pharma - PR Newswire |
| Abbott Laboratories to Pay States $22.5 Million in TriCor Deal | January 08, 2010 | BioSpace |
| Abbott Laboratories's XIENCE V(R) Approved in Japan - Second Largest Drug Eluting Stent Market Worldwide | January 08, 2010 | BioSpace |
| Mo. to get $1.2M in Abbott settlement | January 07, 2010 | Health News - BizJournals.com |
| Abbott Lab settlement brings $1.5 million to Florida | January 07, 2010 | Health News - BizJournals.com |
| New Abbott Gene-Based Test for Colorectal Cancer Receives CE Mark | January 07, 2010 | Pharma News - PharmiWeb |
| Abbott to Present at J.P. Morgan Healthcare Conference | January 04, 2010 | Pharma News - PR Newswire |
| Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2009 Earnings | January 04, 2010 | Biotech News - PR Newswire |
| US Warns Abbott Laboratories Unit on Problems at Swedish Plant | December 16, 2009 | BioSpace - Breaking News |
| US Warns Abbott Laboratories Unit on Problems at Swedish Plant | December 16, 2009 | BioSpace |
| Abbott Acquires LIMS Company | December 15, 2009 | Contract Pharma |
| Abbott Boosts Informatics Portfolio with $123M Acquisition of StarLims | December 15, 2009 | GEN News Highlights |
| Abbott Laboratories Seeks FDA Approval of New Dosage Strengths of SIMCOR(R) (niacin extended-release/simvastatin) | December 10, 2009 | BioSpace - Breaking News |
| US Group Asks FDA To Ban Abbott Laboratories Diet Drug | December 04, 2009 | BioSpace - Breaking News |
| Abbott drug safety in FDA spotlight | December 04, 2009 | FiercePharma |
| US Group Asks FDA To Ban Abbott Laboratories Diet Drug | December 04, 2009 | BioSpace |
| Abbott's Ibis Technology Named One of the Top Innovations for 2009 by The Scientist | December 02, 2009 | Biotech News - PR Newswire |
| Abbott gives Teva TriCor rights in 2011 | December 01, 2009 | FiercePharma |
| Abbott Laboratories Settles Tricor Patent Row with Teva Pharmaceutical Industries Limited | December 01, 2009 | BioSpace |
| U.S., Europe reviews safety of Abbott obesity med | November 23, 2009 | FiercePharma |
